This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma

This study is currently recruiting participants.
See Contacts and Locations
Verified May 2017 by National Cancer Institute (NCI)
Sponsor:
Information provided by (Responsible Party):
National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:
NCT02224781
First received: August 22, 2014
Last updated: July 20, 2017
Last verified: May 2017
  Purpose
This randomized phase III trial studies how well initial treatment with ipilimumab and nivolumab followed by dabrafenib and trametinib works and compares it to initial treatment with dabrafenib and trametinib followed by ipilimumab and nivolumab in treating patients with stage III-IV melanoma that contains a mutation known as BRAFV600 and cannot be removed by surgery. Ipilimumab and nivolumab may block tumor growth by targeting certain cells. Dabrafenib and trametinib may block tumor growth by targeting the BRAFV600 gene. It is not yet known whether treating patients with ipilimumab and nivolumab followed by dabrafenib and trametinib is more effective than treatment with dabrafenib and trametinib followed by ipilimumab and nivolumab.

Condition Intervention Phase
BRAF NP_004324.2:p.V600X Metastatic Melanoma Recurrent Melanoma Stage III Skin Melanoma Stage IIIA Skin Melanoma Stage IIIB Skin Melanoma Stage IIIC Skin Melanoma Stage IV Skin Melanoma Drug: Dabrafenib Biological: Ipilimumab Other: Laboratory Biomarker Analysis Biological: Nivolumab Other: Quality-of-Life Assessment Drug: Trametinib Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: No masking
Primary Purpose: Treatment
Official Title: A Randomized Phase III Trial of Dabrafenib + Trametinib Followed by Ipilimumab + Nivolumab at Progression vs. Ipilimumab + Nivolumab Followed by Dabrafenib + Trametinib at Progression in Patients With Advanced BRAFV600 Mutant Melanoma

Resource links provided by NLM:


Further study details as provided by National Cancer Institute (NCI):

Primary Outcome Measures:
  • OS rate, defined as the proportion of patients alive after 2 years of follow-up time [ Time Frame: The time from randomization to death from any cause, assessed for up to 2 years ]
    Will be estimated and compared between the two arms using the Mantel-Haenszel test based (stratified by ECOG performance status [PS] and LDH) based on two-sided overall type I error rate of 0.05 adjusting for two-interim analysis. Mantel-Haenszel test will compare the 2-year OS rates while controlling for the stratification factors. The difference in 2-year OS rates in arms A and B will be estimated and presented with 95% repeated confidence interval of Jennison-Turnbull. In addition, OS distribution will be estimated using the Kaplan-Meier method. The distribution of OS will be compared using


Secondary Outcome Measures:
  • PFS, evaluated based on RECIST version 1.1 [ Time Frame: The time from randomization to disease progression or death (whichever occurs first), assessed up to 5 years ]
    Distribution will be estimated using the Kaplan-Meier method. PFS will be compared using the log-rank test.

  • Response rate according to RECIST version 1.1 [ Time Frame: Up to 5 years ]
    Response rates will be compared using the Mantel-Haenszel test (stratified by ECOG PS and LDH) test in arms A vs. B. Response rate for patients who are treated with ipilimumab/nivolumab before crossover (arm A) vs. for patients who were initially treated with dabrafenib/trametinib and crossed over to ipilimumab/nivolumab will be compared (arm D). Response rates will be compared using the Fisher's exact test.

  • Toxicity rate for categorized AEs [ Time Frame: Up to 5 years ]
    Compared using the chi-square of Fisher's exact test. Two-sided p-values will be reported for these comparisons.

  • Toxicity rate for individual adverse events (AEs) [ Time Frame: Up to 5 years ]
    Compared using the chi-square of Fisher's exact test. Two-sided p-values will be reported for these comparisons.

  • Toxicity rate for worst degree AEs [ Time Frame: Up to 5 years ]
    Compared using the chi-square of Fisher's exact test. Two-sided p-values will be reported for these comparisons.


Other Outcome Measures:
  • Change in patient-reported symptoms, assessed using the Patient Reported Outcomes Common Terminology Criteria for Adverse Events [ Time Frame: Baseline to up to 6 months after the initiation of treatment in each step ]
    To evaluate the effect of treatment sequence on symptoms, summary statistics (frequency [N] and percentage [%]) will be reported with respect to presence, frequency and severity (if applicable) for each symptom by treatment sequence for ipilimumab + nivolumab (arm A vs. D), and for dabrafenib + trametinib (arm B vs. C) at baseline, 6-, 12-weeks, and 6-months after the initiation of the first treatment and the secondary treatment.

  • Genetic characteristics [ Time Frame: Baseline ]
    Genetic associations with irAE status will be assessed using Fisher's exact test, one-degree-of-freedom genotypic trend test or the two-degrees-of-freedom chi-squared test of independence at each individual SNP marker. Tests of association will be adjusted for age, sex, center or clinical protocol, and dose as well as American Joint Committee on Cancer stage, ulceration, performance status, LDH level, number of involved sites, BRAF mutation status (when available) and number of prior therapies using logistic regression modeling assuming an additive genetic model.

  • irAE status [ Time Frame: Up to 2 years ]
    Genetic associations with irAE status will be assessed using Fisher's exact test, one-degree-of-freedom genotypic trend test or the two-degrees-of-freedom chi-squared test of independence at each individual SNP marker. Tests of association will be adjusted for age, sex, center or clinical protocol, and dose as well as American Joint Committee on Cancer stage, ulceration, performance status, LDH level, number of involved sites, BRAF mutation status (when available) and number of prior therapies using logistic regression modeling assuming an additive genetic model.

  • Overall function, assessed using Patient-Reported Outcomes Measurement Information System PROFILE-29 [ Time Frame: Up to 24 months from study entry ]
    A log-normal survival model for analyzing longitudinal data which incorporates the non-ignorable censoring mechanism will be fitted for each short form T-score and pain intensity, separately, to assess initial treatment effect (i.e., arm A: ipilimumab + nivolumab [with subsequent dabrafenib + trametinib] vs. arm B: dabrafenib + trametinib [with subsequent ipilimumab + nivolumab]) on each function. To evaluate the effect of treatment sequence on patient function, each of the PROMIS short form T-score and pain intensity (with longitudinal data collected at baseline, 6-, 12-weeks, and 6-months af

  • Quality-adjusted time without symptoms of disease progression or toxicity of treatment (Q-TWIST) [ Time Frame: Up to 2 years ]
    The restricted mean amount of time for each health state will be estimated using the Kaplan-Meier method, with time limit set at 2 years for computation of all restricted means. The mean amount of time for each health state and the average group utility scores will be summarized by initial treatment (i.e., arm A: ipilimumab + nivolumab [with subsequent dabrafenib + trametinib] vs. arm B: dabrafenib + trametinib [with subsequent ipilimumab + nivolumab]). The Q-TWiST subscore and the overall Q-TWiST score will then be reported by initial treatment. Differences between treatment groups in the mea


Estimated Enrollment: 300
Actual Study Start Date: July 13, 2015
Estimated Primary Completion Date: July 13, 2019 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Arm A (immunotherapy)

IMMUNOTHERAPY INDUCTION (COURSES 1-2): Patients receive nivolumab IV over 60 minutes and ipilimumab IV over 90 minutes on days 1 and 22. Treatment repeats every 6 weeks for 2 courses in the absence of disease progression or unacceptable toxicity.

IMMUNOTHERAPY MAINTENANCE (COURSES 3-14): Patients receive nivolumab IV over 60 minutes on days 1, 15, and 29. Treatment repeats every 6 weeks for up to 12 courses in the absence of disease progression or unacceptable toxicity. Upon disease progression, patients re-register and cross over to Arm C.

Biological: Ipilimumab
Given IV
Other Names:
  • Anti-Cytotoxic T-Lymphocyte-Associated Antigen-4 Monoclonal Antibody
  • BMS-734016
  • MDX-010
  • MDX-CTLA4
  • Yervoy
Other: Laboratory Biomarker Analysis
Correlative studies
Biological: Nivolumab
Given IV
Other Names:
  • BMS-936558
  • MDX-1106
  • NIVO
  • ONO-4538
  • Opdivo
Other: Quality-of-Life Assessment
Ancillary studies
Other Name: Quality of Life Assessment
Experimental: Arm B (BRAF inhibitor therapy)
Patients receive dabrafenib PO BID and trametinib PO daily on days 1-42. Courses repeat every 6 weeks in the absence of disease progression or unacceptable toxicity. Upon disease progression, patients re-register and cross over to Arm D.
Drug: Dabrafenib
Given PO
Other Names:
  • BRAF Inhibitor GSK2118436
  • GSK-2118436A
  • GSK2118436
Other: Laboratory Biomarker Analysis
Correlative studies
Other: Quality-of-Life Assessment
Ancillary studies
Other Name: Quality of Life Assessment
Drug: Trametinib
Given PO
Other Names:
  • GSK1120212
  • JTP-74057
  • MEK Inhibitor GSK1120212
  • Mekinist
Experimental: Arm C (BRAF inhibitor therapy)
Patients receive dabrafenib PO BID and trametinib PO daily on days 1-42. Courses repeat every 6 weeks in the absence of disease progression or unacceptable toxicity.
Drug: Dabrafenib
Given PO
Other Names:
  • BRAF Inhibitor GSK2118436
  • GSK-2118436A
  • GSK2118436
Other: Laboratory Biomarker Analysis
Correlative studies
Other: Quality-of-Life Assessment
Ancillary studies
Other Name: Quality of Life Assessment
Drug: Trametinib
Given PO
Other Names:
  • GSK1120212
  • JTP-74057
  • MEK Inhibitor GSK1120212
  • Mekinist
Experimental: Arm D (immunotherapy)

IMMUNOTHERAPY INDUCTION (COURSES 1-2): Patients receive nivolumab IV over 60 minutes and ipilimumab IV over 90 minutes on days 1 and 22. Treatment repeats every 6 weeks for 2 courses in the absence of disease progression or unacceptable toxicity.

IMMUNOTHERAPY MAINTENANCE (COURSES 3-14): Patients receive nivolumab IV over 60 minutes on days 1, 15, and 29. Treatment repeats every 6 weeks for up to 12 courses in the absence of disease progression or unacceptable toxicity.

Biological: Ipilimumab
Given IV
Other Names:
  • Anti-Cytotoxic T-Lymphocyte-Associated Antigen-4 Monoclonal Antibody
  • BMS-734016
  • MDX-010
  • MDX-CTLA4
  • Yervoy
Other: Laboratory Biomarker Analysis
Correlative studies
Biological: Nivolumab
Given IV
Other Names:
  • BMS-936558
  • MDX-1106
  • NIVO
  • ONO-4538
  • Opdivo
Other: Quality-of-Life Assessment
Ancillary studies
Other Name: Quality of Life Assessment

  Show Detailed Description

  Eligibility

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • STEP 1
  • Eastern Cooperative Oncology Group (ECOG) performance status: 0 or 1
  • Women must not be pregnant or breast-feeding

    • All females of childbearing potential must have a blood test or urine study within 2 weeks prior to registration to rule out pregnancy
    • A female of childbearing potential is any woman, regardless of sexual orientation or whether they have undergone tubal ligation, who meets the following criteria: 1) has not undergone a hysterectomy or bilateral oophorectomy; or 2) has not been naturally postmenopausal for at least 24 consecutive months (i.e., has had menses at any time in the preceding 24 consecutive months)
  • Women of child-bearing potential and sexually active males must agree to use at least two other accepted and effective methods of contraception and/or to abstain from sexual intercourse for the duration of their participation in the study, and for at least 4 weeks after treatment with dabrafenib or for 4 months after dabrafenib in combination with trametinib; women of child-bearing potential must use at least two other accepted and effective methods of contraception and/or to abstain from sexual intercourse for at least 5 months after the last dose of nivolumab and/or ipilimumab and sexually active males must use at least two other accepted and effective methods of contraception and/or abstain from sexual intercourse for at least 7 months after the last dose of nivolumab and/or ipilimumab; should a woman become pregnant or suspect she is pregnant while she is participating in this study, she should inform her treating physician immediately
  • Patients must have unresectable stage III or stage IV disease
  • Patients must have measurable disease; all sites of disease must be evaluated within 4 weeks prior to randomization
  • Patients must have histological or cytological confirmation of melanoma that is metastatic or unresectable and clearly progressive

    • NOTE: Any patient with BRAF V600 mutant melanoma (whether cutaneous, acral or mucosal primary) who meets the eligibility criteria is eligible for participation in this trial; patients with uveal melanoma are not eligible for this trial
  • Patients must have BRAF V600 mutation, identified by a Food and Drug Administration (FDA)-approved test at a Clinical Laboratory Improvement Act (CLIA)-certified lab; if test at CLIA-certified lab used a non-FDA approved method, information about the assay must be provided (FDA approved tests for BRAF V600 mutations in melanoma include: THxID BRAF Detection Kit and Cobas 4800 BRAF V600 Mutation Test)
  • Patients may have had prior systemic therapy in the adjuvant setting; however this adjuvant treatment must not have included a CTLA4 or PD1 pathway blocking antibody or a BRAF/MEK inhibitor; also, patients may not have had any prior systemic treatment for advanced (measurable metastatic) disease
  • Patients must have discontinued chemotherapy, immunotherapy or other investigational agents used in the adjuvant setting >= 4 weeks prior to entering the study and recovered from adverse events due to those agents; mitomycin and nitrosoureas must have been discontinued at least 6 weeks prior to entering the study; patients must have discontinued radiation therapy >= 2 weeks prior to entering the study and recovered from any adverse events associated with treatment; prior surgery must be >= 4 weeks from registration and patients must be fully recovered from post-surgical complications
  • Patients must not receive any other investigational agents while on study or within four weeks prior to registration
  • Patients are ineligible if they have any currently active central nervous system (CNS) metastases; patients who have treated brain metastases (with either surgical resection or stereotactic radiosurgery [SRS]) that have been stable on head magnetic resonance imaging (MRI) or contrast computed tomography (CT) scan for at least 4 weeks following treatment and within 4 weeks of randomization could be eligible; patients must not have taken any steroids =< 14 days prior to randomization for the purpose of managing their brain metastases; patients with only whole brain irradiation for treatment of CNS metastases will be ineligible
  • Patients must not have other current malignancies, other than basal cell skin cancer, squamous cell skin cancer, in situ cervical cancer, ductal or lobular carcinoma in situ of the breast; patients with other malignancies are eligible if they have been continuously disease-free for > 3 years prior to the time of registration; patients with history of RAS mutation-positive tumors are not eligible regardless of interval from the current study; Note: prospective RAS testing is not required; however, if the results of previous RAS testing are known, they must be used in assessing eligibility
  • White blood count >= 3,000/uL
  • Absolute neutrophil count (ANC) >= 1,500/uL
  • Platelet count >= 100,000/uL
  • Hemoglobin > 9 g/dL
  • Serum creatinine =< 1.5 x upper limit of normal (ULN) or serum creatinine clearance (CrCl) >= 40 ml/min
  • Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) =< 3 x ULN (=< 5 x ULN for patients with documented liver metastases)
  • Alkaline phosphatase =< 2 x ULN (=< 5 x ULN for patients with known liver involvement and =< 7 x ULN for patients with known bone involvement)
  • Total bilirubin =< 1.5 x ULN except subjects with normal direct bilirubin or those with known Gilbert's syndrome
  • Serum lactate dehydrogenase (LDH) < 10 X ULN (patients with LDH > 10 X ULN are felt to have aggressive disease and should be considered for BRAF inhibitor therapy off protocol)
  • Patients must not have any serious or unstable pre-existing medical conditions (aside from malignancy exceptions specified above), including but not limited to, ongoing or active infection requiring parenteral antibiotics on day 1, history of bleeding diathesis or need for concurrent anticoagulation (international normalized ratio [INR] =< 1.5 and partial thromboplastin time [PTT] within 1.1 x ULN), or psychiatric illness/social situations that would limit compliance with study requirements, interfere with subject's safety, or obtaining informed consent; therapeutic level dosing of warfarin can be used with close monitoring of prothrombin time (PT)/INR by the site; exposure may be decreased due to enzyme induction when on treatment, thus warfarin dosing may need to be adjusted based upon PT/INR; consequently, when discontinuing dabrafenib, warfarin exposure may be increased and thus close monitoring via PT/INR and warfarin dose adjustments must be made as clinically appropriate; prophylactic low dose warfarin may be given to maintain central catheter patency
  • Patients must not have a history of or evidence of cardiovascular risks including any of the following:

    • QT interval corrected for heart rate using the Bazett's formula (QTcB) >= 480 msec. at baseline
    • History of acute coronary syndromes (including myocardial infarction or unstable angina), coronary angioplasty, or stenting within the past 24 weeks prior to registration
    • History prior to registration or evidence of current >= class II congestive heart failure as defined by the New York Heart Association (NYHA) functional classification system
    • Left ventricular ejection fraction (LVEF) =< lower limit of normal on cardiac echocardiogram (echo) or multi gated acquisition scan (MUGA)
    • Intra-cardiac defibrillator
    • History of abnormal cardiac valve morphology (>= grade 2) documented by ECHO (subjects with grade 1 abnormalities [i.e., mild regurgitation/stenosis] can be entered on study); subjects with moderate valvular thickening should not be entered on study
    • History or evidence of current clinically significant uncontrolled cardiac arrhythmias; clarification: subjects with atrial fibrillation controlled for > 30 days prior to dosing are eligible
    • Treatment refractory hypertension defined as a blood pressure of systolic > 140 mmHg and/or diastolic > 90 mm Hg which cannot be controlled by anti-hypertensive therapy
  • Individuals who are known to be human immunodeficiency virus (HIV) infected are eligible (note: HIV testing is not required for entry into the study)
  • Patients with evidence of active hepatitis B virus (HBV) or hepatitis C Virus (HCV) infection are not eligible; patients with cleared HBV and HCV infection will be allowed
  • Patients with active autoimmune disease or history of autoimmune disease that might recur, which may affect vital organ function or require immune suppressive treatment including systemic corticosteroids, should be excluded; these include but are not limited to patients with a history of immune related neurologic disease, multiple sclerosis, autoimmune (demyelinating) neuropathy, Guillain-Barre syndrome, myasthenia gravis; systemic autoimmune disease such as systemic lupus erythematosus (SLE), connective tissue diseases, scleroderma, inflammatory bowel disease (IBD), Crohn's, ulcerative colitis, hepatitis; and patients with a history of toxic epidermal necrolysis (TEN), Stevens-Johnson syndrome, or phospholipid syndrome should be excluded; patients with vitiligo, endocrine deficiencies including thyroiditis managed with replacement hormones including physiologic corticosteroids are eligible; patients with rheumatoid arthritis and other arthropathies, Sjögren's syndrome and psoriasis controlled with topical medication and patients with positive serology, such as antinuclear antibodies (ANA), should be evaluated for the presence of target organ involvement and potential need for systemic treatment; if no systemic immune suppression is deemed necessary they can be eligible
  • The following medications or non-drug therapies are also prohibited while on treatment in this study:

    • Other anti-cancer therapies
    • Other investigational drugs
    • Patients taking any medications or substances that are strong inhibitors or inducers of CYP3A or CYP2C8 are ineligible
  • Patients must not have history of retinal vein occlusion (RVO)
  • Patients must not have evidence of interstitial lung disease or pneumonitis
  • Patients must not have malabsorption, swallowing difficulty, or other conditions that would interfere with the ingestion or absorption of dabrafenib or trametinib
  • STEP 2 (CROSSOVER ARM FOR PATIENTS WITH PROGRESSIVE DISEASE)
  • The patient must have met all eligibility criteria (except as detailed below) at the time of crossover

    • RECIST defined measurable disease is not required
    • Only prior systemic therapy as part of step 1 is allowed; patients who received allowed systemic therapy in the adjuvant setting prior to Step 1 and were eligible for Step 1 are not excluded from proceeding to Step 2 if they meet other eligibility criteria
    • Malabsorption, swallowing difficulty, or other conditions that would interfere with the ingestion or absorption of dabrafenib or trametinib, or history of retinal vein occlusion are acceptable for patients crossing over to ipilimumab + nivolumab treatment
    • History of autoimmune disease, excluding interstitial lung disease or pneumonitis, is allowed in patients crossing over to dabrafenib/trametinib therapy
    • Patients can be less than 4 weeks from surgery or SRS to CNS metastases
    • There is no restriction on serum LDH at crossover
    • Patients with a history of cardiovascular risks that developed during step 1 of therapy should be discussed with study principal investigator (PI) at time of crossover
  • Patients must have melanoma that is metastatic and clearly progressive on prior therapy
  • Patients must be at least 2 weeks and within 12 weeks from documented progressive disease (PD) on Step 1 of current study; all sites of disease must be evaluated within 4 weeks prior to registration
  • Patients must have recovered from adverse events (toxicities resolved to grade 1 or less) of prior therapy; patients with immune related toxicities from ipilimumab + nivolumab may continue onto Step 2 even if still on steroids to control side effects, so long as toxicity has resolved to grade 1 or less
  • Patients must have discontinued radiation therapy >= 2 weeks prior to registering to Step 2 of the study and recovered from any adverse events associated with treatment; prior surgery must be >= 2 weeks from registration to Step 2 and patients must be fully recovered from post-surgical complications
  • Patients are ineligible if they have any currently active CNS metastases; patients who have treated brain metastases (with either surgical resection or SRS) that have been stable on head MRI or contrast CT scan for at least 4 weeks following treatment and within 4 weeks prior to Step 2 registration are eligible; patients crossing over to ipilimumab + nivolumab must not have taken any steroids =< 14 days prior to registration for the purpose of managing their brain metastases; this exclusion does not apply for patients crossing over to dabrafenib + trametinib; patients with only whole brain irradiation for treatment of CNS metastases are ineligible
  • Patients must not have other current malignancies, other than basal cell skin cancer, squamous cell skin cancer, in situ cervical cancer, ductal or lobular carcinoma in situ of the breast
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT02224781

  Hide Study Locations
Locations
United States, Alabama
University of Alabama at Birmingham Cancer Center Recruiting
Birmingham, Alabama, United States, 35233
Contact: Robert M. Conry    800-828-8816      
Principal Investigator: Robert M. Conry         
United States, Alaska
Anchorage Associates in Radiation Medicine Recruiting
Anchorage, Alaska, United States, 98508
Contact: Alison K. Conlin    503-215-2614    CanRsrchStudies@providence.org   
Principal Investigator: Alison K. Conlin         
Anchorage Radiation Therapy Center Suspended
Anchorage, Alaska, United States, 99504
Alaska Breast Care and Surgery LLC Recruiting
Anchorage, Alaska, United States, 99508
Contact: Alison K. Conlin    503-215-2614    CanRsrchStudies@providence.org   
Principal Investigator: Alison K. Conlin         
Alaska Oncology and Hematology LLC Recruiting
Anchorage, Alaska, United States, 99508
Contact: Alison K. Conlin    503-215-2614    CanRsrchStudies@providence.org   
Principal Investigator: Alison K. Conlin         
Alaska Women's Cancer Care Recruiting
Anchorage, Alaska, United States, 99508
Contact: Alison K. Conlin    503-215-2614    CanRsrchStudies@providence.org   
Principal Investigator: Alison K. Conlin         
Anchorage Oncology Centre Recruiting
Anchorage, Alaska, United States, 99508
Contact: Alison K. Conlin    503-215-2614    CanRsrchStudies@providence.org   
Principal Investigator: Alison K. Conlin         
Katmai Oncology Group Recruiting
Anchorage, Alaska, United States, 99508
Contact: Alison K. Conlin    503-215-2614    CanRsrchStudies@providence.org   
Principal Investigator: Alison K. Conlin         
Providence Alaska Medical Center Recruiting
Anchorage, Alaska, United States, 99508
Contact: Alison K. Conlin    503-215-2614    CanRsrchStudies@providence.org   
Principal Investigator: Alison K. Conlin         
Fairbanks Memorial Hospital Recruiting
Fairbanks, Alaska, United States, 99701
Contact: John A. Keech    253-403-2394      
Principal Investigator: John A. Keech         
United States, Arkansas
Mercy Cancer Center-Hot Springs Recruiting
Hot Springs, Arkansas, United States, 71913
Contact: Mehmet S. Copur    800-998-2119      
Principal Investigator: Mehmet S. Copur         
University of Arkansas for Medical Sciences Recruiting
Little Rock, Arkansas, United States, 72205
Contact: Fade A. Mahmoud    501-686-8274      
Principal Investigator: Fade A. Mahmoud         
United States, California
Kaiser Permanente-Anaheim Recruiting
Anaheim, California, United States, 92807
Contact: Gary L. Buchschacher    626-564-3455      
Principal Investigator: Gary L. Buchschacher         
Sutter Auburn Faith Hospital Recruiting
Auburn, California, United States, 95602
Contact: Jorge A. Garcia-Young    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Jorge A. Garcia-Young         
Sutter Cancer Centers Radiation Oncology Services-Auburn Recruiting
Auburn, California, United States, 95603
Contact: Jorge A. Garcia-Young    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Jorge A. Garcia-Young         
Kaiser Permanente-Baldwin Park Recruiting
Baldwin Park, California, United States, 91706
Contact: Gary L. Buchschacher    626-564-3455      
Principal Investigator: Gary L. Buchschacher         
Kaiser Permanente-Bellflower Recruiting
Bellflower, California, United States, 90706
Contact: Gary L. Buchschacher    626-564-3455      
Principal Investigator: Gary L. Buchschacher         
Alta Bates Summit Medical Center-Herrick Campus Recruiting
Berkeley, California, United States, 94704
Contact: Jorge A. Garcia-Young    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Jorge A. Garcia-Young         
Providence Saint Joseph Medical Center/Disney Family Cancer Center Recruiting
Burbank, California, United States, 91505
Contact: Alison K. Conlin    503-215-2614    CanRsrchStudies@providence.org   
Principal Investigator: Alison K. Conlin         
Sutter Cancer Centers Radiation Oncology Services-Cameron Park Recruiting
Cameron Park, California, United States, 95682
Contact: Jorge A. Garcia-Young    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Jorge A. Garcia-Young         
Sutter Davis Hospital Recruiting
Davis, California, United States, 95616
Contact: Jorge A. Garcia-Young    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Jorge A. Garcia-Young         
City of Hope Comprehensive Cancer Center Recruiting
Duarte, California, United States, 91010
Contact: Kim A. Margolin    800-826-4673    becomingapatient@coh.org   
Principal Investigator: Kim A. Margolin         
Kaiser Permanente Hospital Recruiting
Fontana, California, United States, 92335
Contact: Gary L. Buchschacher    626-564-3455      
Principal Investigator: Gary L. Buchschacher         
Kaiser Permanente Recruiting
Fresno, California, United States, 93720
Contact: Tatjana Kolevska    626-564-3455      
Principal Investigator: Tatjana Kolevska         
Kaiser Permanente - Harbor City Recruiting
Harbor City, California, United States, 90710
Contact: Gary L. Buchschacher    626-564-3455      
Principal Investigator: Gary L. Buchschacher         
Kaiser Permanente-Irvine Recruiting
Irvine, California, United States, 92618
Contact: Gary L. Buchschacher    626-564-3455      
Principal Investigator: Gary L. Buchschacher         
Kaiser Permanente Los Angeles Medical Center Recruiting
Los Angeles, California, United States, 90027
Contact: Gary L. Buchschacher    626-564-3455      
Principal Investigator: Gary L. Buchschacher         
Kaiser Permanente-Cadillac Recruiting
Los Angeles, California, United States, 90034
Contact: Gary L. Buchschacher    626-564-3455      
Principal Investigator: Gary L. Buchschacher         
UCLA / Jonsson Comprehensive Cancer Center Recruiting
Los Angeles, California, United States, 90095
Contact: Bartosz Chmielowski    888-798-0719      
Principal Investigator: Bartosz Chmielowski         
Palo Alto Medical Foundation-Camino Division Recruiting
Mountain View, California, United States, 94040
Contact: Jorge A. Garcia-Young    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Jorge A. Garcia-Young         
Palo Alto Medical Foundation-Gynecologic Oncology Recruiting
Mountain View, California, United States, 94040
Contact: Jorge A. Garcia-Young    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Jorge A. Garcia-Young         
Sutter Cancer Research Consortium Recruiting
Novato, California, United States, 94945
Contact: Jorge A. Garcia-Young    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Jorge A. Garcia-Young         
Kaiser Permanente-Oakland Recruiting
Oakland, California, United States, 94611
Contact: Tatjana Kolevska    626-564-3455      
Principal Investigator: Tatjana Kolevska         
Kaiser Permanente-Ontario Recruiting
Ontario, California, United States, 91761
Contact: Gary L. Buchschacher    626-564-3455      
Principal Investigator: Gary L. Buchschacher         
Palo Alto Medical Foundation Health Care Recruiting
Palo Alto, California, United States, 94301
Contact: Jorge A. Garcia-Young    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Jorge A. Garcia-Young         
Kaiser Permanente - Panorama City Recruiting
Panorama City, California, United States, 91402
Contact: Gary L. Buchschacher    626-564-3455      
Principal Investigator: Gary L. Buchschacher         
Feather River Cancer Center Recruiting
Paradise, California, United States, 95969
Contact: Sam Mazj    530-876-7995    haleew@ah.org   
Principal Investigator: Sam Mazj         
City of Hope Rancho Cucamonga Recruiting
Rancho Cucamonga, California, United States, 91730
Contact: Kim A. Margolin    800-826-4673    becomingapatient@coh.org   
Principal Investigator: Kim A. Margolin         
Kaiser Permanente-Richmond Recruiting
Richmond, California, United States, 94801
Contact: Tatjana Kolevska    626-564-3455      
Principal Investigator: Tatjana Kolevska         
Kaiser Permanente-Riverside Recruiting
Riverside, California, United States, 92505
Contact: Gary L. Buchschacher    626-564-3455      
Principal Investigator: Gary L. Buchschacher         
Kaiser Permanente-Roseville Recruiting
Roseville, California, United States, 95661
Contact: Tatjana Kolevska    626-564-3455      
Principal Investigator: Tatjana Kolevska         
Sutter Cancer Centers Radiation Oncology Services-Roseville Recruiting
Roseville, California, United States, 95661
Contact: Jorge A. Garcia-Young    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Jorge A. Garcia-Young         
Sutter Roseville Medical Center Recruiting
Roseville, California, United States, 95661
Contact: Jorge A. Garcia-Young    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Jorge A. Garcia-Young         
Sutter Medical Center Sacramento Recruiting
Sacramento, California, United States, 95816
Contact: Jorge A. Garcia-Young    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Jorge A. Garcia-Young         
Kaiser Permanente - Sacramento Recruiting
Sacramento, California, United States, 95825
Contact: Tatjana Kolevska    626-564-3455      
Principal Investigator: Tatjana Kolevska         
Kaiser Permanente-San Diego Mission Recruiting
San Diego, California, United States, 92108
Contact: Gary L. Buchschacher    626-564-3455      
Principal Investigator: Gary L. Buchschacher         
Kaiser Permanente-San Diego Zion Recruiting
San Diego, California, United States, 92120
Contact: Gary L. Buchschacher    626-564-3455      
Principal Investigator: Gary L. Buchschacher         
California Pacific Medical Center-Pacific Campus Recruiting
San Francisco, California, United States, 94115
Contact: Jorge A. Garcia-Young    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Jorge A. Garcia-Young         
Kaiser Permanente-San Marcos Recruiting
San Marcos, California, United States, 92069
Contact: Gary L. Buchschacher    626-564-3455      
Principal Investigator: Gary L. Buchschacher         
Kaiser Permanente Medical Center - Santa Clara Recruiting
Santa Clara, California, United States, 95051
Contact: Tatjana Kolevska    626-564-3455      
Principal Investigator: Tatjana Kolevska         
Palo Alto Medical Foundation-Santa Cruz Recruiting
Santa Cruz, California, United States, 95065
Contact: Jorge A. Garcia-Young    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Jorge A. Garcia-Young         
Palo Alto Medical Foundation-Sunnyvale Recruiting
Sunnyvale, California, United States, 94086
Contact: Jorge A. Garcia-Young    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Jorge A. Garcia-Young         
Sutter Cancer Centers Radiation Oncology Services-Vacaville Recruiting
Vacaville, California, United States, 95687
Contact: Jorge A. Garcia-Young    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Jorge A. Garcia-Young         
Kaiser Permanente-Vallejo Recruiting
Vallejo, California, United States, 94589
Contact: Tatjana Kolevska    626-564-3455      
Principal Investigator: Tatjana Kolevska         
Kaiser Permanente-Walnut Creek Recruiting
Walnut Creek, California, United States, 94596
Contact: Tatjana Kolevska    626-564-3455      
Principal Investigator: Tatjana Kolevska         
Kaiser Permanente Recruiting
Woodland Hills, California, United States, 91367
Contact: Gary L. Buchschacher    626-564-3455      
Principal Investigator: Gary L. Buchschacher         
United States, Colorado
The Medical Center of Aurora Suspended
Aurora, Colorado, United States, 80012
University of Colorado Cancer Center - Anschutz Cancer Pavilion Recruiting
Aurora, Colorado, United States, 80045
Contact: Karl D. Lewis    720-848-0650      
Principal Investigator: Karl D. Lewis         
Boulder Community Hospital Recruiting
Boulder, Colorado, United States, 80301
Contact: Keren Sturtz    303-777-2663    ccrp@co-cancerresearch.org   
Principal Investigator: Keren Sturtz         
Penrose-Saint Francis Healthcare Recruiting
Colorado Springs, Colorado, United States, 80907
Contact: Mehmet S. Copur    800-998-2119      
Principal Investigator: Mehmet S. Copur         
Rocky Mountain Cancer Centers-Penrose Recruiting
Colorado Springs, Colorado, United States, 80907
Contact: Mehmet S. Copur    800-998-2119      
Principal Investigator: Mehmet S. Copur         
Memorial Hospital Central Recruiting
Colorado Springs, Colorado, United States, 80909
Contact: Karl D. Lewis    720-848-0650      
Principal Investigator: Karl D. Lewis         
Porter Adventist Hospital Recruiting
Denver, Colorado, United States, 80210
Contact: Mehmet S. Copur    800-998-2119      
Principal Investigator: Mehmet S. Copur         
Presbyterian - Saint Lukes Medical Center - Health One Recruiting
Denver, Colorado, United States, 80218
Contact: Keren Sturtz    303-777-2663    ccrp@co-cancerresearch.org   
Principal Investigator: Keren Sturtz         
SCL Health Saint Joseph Hospital Recruiting
Denver, Colorado, United States, 80218
Contact: Keren Sturtz    303-777-2663    ccrp@co-cancerresearch.org   
Principal Investigator: Keren Sturtz         
Rose Medical Center Recruiting
Denver, Colorado, United States, 80220
Contact: Keren Sturtz    303-777-2663    ccrp@co-cancerresearch.org   
Principal Investigator: Keren Sturtz         
Mercy Medical Center Recruiting
Durango, Colorado, United States, 81301
Contact: Mehmet S. Copur    800-998-2119      
Principal Investigator: Mehmet S. Copur         
Southwest Oncology PC Recruiting
Durango, Colorado, United States, 81301
Contact: Mehmet S. Copur    800-998-2119      
Principal Investigator: Mehmet S. Copur         
Comprehensive Cancer Care and Research Institute of Colorado LLC Recruiting
Englewood, Colorado, United States, 80113
Contact: Keren Sturtz    303-777-2663    ccrp@co-cancerresearch.org   
Principal Investigator: Keren Sturtz         
Swedish Medical Center Recruiting
Englewood, Colorado, United States, 80113
Contact: Keren Sturtz    303-777-2663    ccrp@co-cancerresearch.org   
Principal Investigator: Keren Sturtz         
Poudre Valley Hospital Recruiting
Fort Collins, Colorado, United States, 80524
Contact: Karl D. Lewis    720-848-0650      
Principal Investigator: Karl D. Lewis         
Mountain Blue Cancer Care Center Recruiting
Golden, Colorado, United States, 80401
Contact: Mehmet S. Copur    800-998-2119      
Principal Investigator: Mehmet S. Copur         
North Colorado Medical Center Recruiting
Greeley, Colorado, United States, 80631
Contact: Keren Sturtz    303-777-2663    ccrp@co-cancerresearch.org   
Principal Investigator: Keren Sturtz         
Rocky Mountain Cancer Centers-Lakewood Recruiting
Lakewood, Colorado, United States, 80228
Contact: Mehmet S. Copur    800-998-2119      
Principal Investigator: Mehmet S. Copur         
Saint Anthony Hospital Recruiting
Lakewood, Colorado, United States, 80228
Contact: Mehmet S. Copur    800-998-2119      
Principal Investigator: Mehmet S. Copur         
Littleton Adventist Hospital Recruiting
Littleton, Colorado, United States, 80122
Contact: Mehmet S. Copur    800-998-2119      
Principal Investigator: Mehmet S. Copur         
Sky Ridge Medical Center Suspended
Lone Tree, Colorado, United States, 80124
Longmont United Hospital Recruiting
Longmont, Colorado, United States, 80501
Contact: Mehmet S. Copur    800-998-2119      
Principal Investigator: Mehmet S. Copur         
Rocky Mountain Cancer Centers-Longmont Recruiting
Longmont, Colorado, United States, 80501
Contact: Mehmet S. Copur    800-998-2119      
Principal Investigator: Mehmet S. Copur         
McKee Medical Center Recruiting
Loveland, Colorado, United States, 80539
Contact: Keren Sturtz    303-777-2663    ccrp@co-cancerresearch.org   
Principal Investigator: Keren Sturtz         
Parker Adventist Hospital Recruiting
Parker, Colorado, United States, 80138
Contact: Mehmet S. Copur    800-998-2119      
Principal Investigator: Mehmet S. Copur         
Rocky Mountain Cancer Centers-Parker Recruiting
Parker, Colorado, United States, 80138
Contact: Mehmet S. Copur    800-998-2119      
Principal Investigator: Mehmet S. Copur         
Saint Mary Corwin Medical Center Recruiting
Pueblo, Colorado, United States, 81004
Contact: Mehmet S. Copur    800-998-2119      
Principal Investigator: Mehmet S. Copur         
Rocky Mountain Cancer Centers - Pueblo Recruiting
Pueblo, Colorado, United States, 81008
Contact: Mehmet S. Copur    800-998-2119      
Principal Investigator: Mehmet S. Copur         
Rocky Mountain Cancer Centers-Thornton Recruiting
Thornton, Colorado, United States, 80260
Contact: Mehmet S. Copur    800-998-2119      
Principal Investigator: Mehmet S. Copur         
SCL Health Lutheran Medical Center Recruiting
Wheat Ridge, Colorado, United States, 80033
Contact: Keren Sturtz    303-777-2663    ccrp@co-cancerresearch.org   
Principal Investigator: Keren Sturtz         
United States, Connecticut
Eastern Connecticut Hematology and Oncology Associates Recruiting
Norwich, Connecticut, United States, 06360
Contact: Dennis E. Slater    860-886-8362      
Principal Investigator: Dennis E. Slater         
Stamford Hospital/Bennett Cancer Center Recruiting
Stamford, Connecticut, United States, 06904
Contact: Salvatore A. Del Prete    203-323-8944      
Principal Investigator: Salvatore A. Del Prete         
United States, Delaware
Christiana Gynecologic Oncology LLC Suspended
Newark, Delaware, United States, 19713
Delaware Clinical and Laboratory Physicians PA Recruiting
Newark, Delaware, United States, 19713
Contact: Gregory A. Masters    302-733-6227      
Principal Investigator: Gregory A. Masters         
Helen F Graham Cancer Center Recruiting
Newark, Delaware, United States, 19713
Contact: Gregory A. Masters    302-733-6227      
Principal Investigator: Gregory A. Masters         
Medical Oncology Hematology Consultants PA Recruiting
Newark, Delaware, United States, 19713
Contact: Gregory A. Masters    302-733-6227      
Principal Investigator: Gregory A. Masters         
Regional Hematology and Oncology PA Recruiting
Newark, Delaware, United States, 19713
Contact: Gregory A. Masters    302-733-6227      
Principal Investigator: Gregory A. Masters         
Christiana Care Health System-Christiana Hospital Recruiting
Newark, Delaware, United States, 19718
Contact: Gregory A. Masters    302-733-6227      
Principal Investigator: Gregory A. Masters         
Christiana Care Health System-Wilmington Hospital Recruiting
Wilmington, Delaware, United States, 19801
Contact: Gregory A. Masters    302-733-6227      
Principal Investigator: Gregory A. Masters         
United States, District of Columbia
MedStar Georgetown University Hospital Recruiting
Washington, D.C., District of Columbia, United States, 20007
Contact: Michael B. Atkins    202-444-2223      
Principal Investigator: Michael B. Atkins         
MedStar Washington Hospital Center Recruiting
Washington, D.C., District of Columbia, United States, 20010
Contact: Michael B. Atkins    202-444-2223      
Principal Investigator: Michael B. Atkins         
United States, Florida
Mount Sinai Comprehensive Cancer Center at Aventura Recruiting
Aventura, Florida, United States, 33180
Contact: Michael A. Schwartz    305-674-2625    info@msccop.com   
Principal Investigator: Michael A. Schwartz         
UM Sylvester Comprehensive Cancer Center at Coral Gables Recruiting
Coral Gables, Florida, United States, 33146
Contact: Nicolas Acquavella Pesantes    305-243-2647      
Principal Investigator: Nicolas Acquavella Pesantes         
Halifax Health Medical Center-Centers for Oncology Recruiting
Daytona Beach, Florida, United States, 32114
Contact: Ruby Anne E. Deveras    386-254-4211      
Principal Investigator: Ruby Anne E. Deveras         
UM Sylvester Comprehensive Cancer Center at Deerfield Beach Recruiting
Deerfield Beach, Florida, United States, 33442
Contact: Nicolas Acquavella Pesantes    305-243-2647      
Principal Investigator: Nicolas Acquavella Pesantes         
Lakeland Regional Health Hollis Cancer Center Suspended
Lakeland, Florida, United States, 33805
Mount Sinai Medical Center Recruiting
Miami Beach, Florida, United States, 33140
Contact: Michael A. Schwartz    305-674-2625    info@msccop.com   
Principal Investigator: Michael A. Schwartz         
University of Miami Miller School of Medicine-Sylvester Cancer Center Recruiting
Miami, Florida, United States, 33136
Contact: Nicolas Acquavella Pesantes    305-243-2647      
Principal Investigator: Nicolas Acquavella Pesantes         
UF Cancer Center at Orlando Health Suspended
Orlando, Florida, United States, 32806
United States, Georgia
University Cancer and Blood Center LLC Recruiting
Athens, Georgia, United States, 30607
Contact: Sharad A. Ghamande    706-721-1663    cancer@augusta.edu   
Principal Investigator: Sharad A. Ghamande         
Emory University/Winship Cancer Institute Recruiting
Atlanta, Georgia, United States, 30322
Contact: Melinda L. Yushak    404-778-1868      
Principal Investigator: Melinda L. Yushak         
Northside Hospital Recruiting
Atlanta, Georgia, United States, 30342
Contact: Ronald G. Steis    404-303-3355    rsteis@atlantacancercare.com   
Principal Investigator: Ronald G. Steis         
Augusta University Medical Center Recruiting
Augusta, Georgia, United States, 30912
Contact: Sharad A. Ghamande    706-721-1663    cancer@augusta.edu   
Principal Investigator: Sharad A. Ghamande         
Northside Hospital-Forsyth Recruiting
Cumming, Georgia, United States, 30041
Contact: Ronald G. Steis    404-303-3355    rsteis@atlantacancercare.com   
Principal Investigator: Ronald G. Steis         
Dekalb Medical Center Recruiting
Decatur, Georgia, United States, 30033
Contact: Sharad A. Ghamande    706-721-1663    cancer@augusta.edu   
Principal Investigator: Sharad A. Ghamande         
Lewis Cancer and Research Pavilion at Saint Joseph's/Candler Recruiting
Savannah, Georgia, United States, 31405
Contact: Howard A. Zaren    912-819-5704      
Principal Investigator: Howard A. Zaren         
United States, Hawaii
Hawaii Oncology Inc-Pali Momi Recruiting
'Aiea, Hawaii, United States, 96701
Contact: Jeffrey L. Berenberg    808-524-6115      
Principal Investigator: Jeffrey L. Berenberg         
Hawaii Cancer Care Inc-POB II Recruiting
Honolulu, Hawaii, United States, 96813
Contact: Jeffrey L. Berenberg    808-524-6115      
Principal Investigator: Jeffrey L. Berenberg         
Hawaii Oncology Inc-POB I Recruiting
Honolulu, Hawaii, United States, 96813
Contact: Jeffrey L. Berenberg    808-524-6115      
Principal Investigator: Jeffrey L. Berenberg         
Queen's Medical Center Recruiting
Honolulu, Hawaii, United States, 96813
Contact: Jeffrey L. Berenberg    808-524-6115      
Principal Investigator: Jeffrey L. Berenberg         
University of Hawaii Cancer Center Recruiting
Honolulu, Hawaii, United States, 96813
Contact: Jeffrey L. Berenberg    808-524-6115      
Principal Investigator: Jeffrey L. Berenberg         
Hawaii Oncology Inc-Kuakini Recruiting
Honolulu, Hawaii, United States, 96817
Contact: Jeffrey L. Berenberg    808-524-6115      
Principal Investigator: Jeffrey L. Berenberg         
Kuakini Medical Center Recruiting
Honolulu, Hawaii, United States, 96817
Contact: Jeffrey L. Berenberg    808-524-6115      
Principal Investigator: Jeffrey L. Berenberg         
United States, Idaho
Saint Alphonsus Cancer Care Center-Boise Recruiting
Boise, Idaho, United States, 83706
Contact: Christopher M. Reynolds    734-712-4673      
Principal Investigator: Christopher M. Reynolds         
Saint Luke's Mountain States Tumor Institute Recruiting
Boise, Idaho, United States, 83712
Contact: Alison K. Conlin    503-215-2614    CanRsrchStudies@providence.org   
Principal Investigator: Alison K. Conlin         
Saint Alphonsus Cancer Care Center-Caldwell Recruiting
Caldwell, Idaho, United States, 83605
Contact: Christopher M. Reynolds    734-712-4673      
Principal Investigator: Christopher M. Reynolds         
Kootenai Medical Center Recruiting
Coeur d'Alene, Idaho, United States, 83814
Contact: Benjamin T. Marchello    800-648-6274      
Principal Investigator: Benjamin T. Marchello         
Walter Knox Memorial Hospital Recruiting
Emmett, Idaho, United States, 83617
Contact: Christopher M. Reynolds    734-712-4673      
Principal Investigator: Christopher M. Reynolds         
Saint Luke's Mountain States Tumor Institute - Fruitland Recruiting
Fruitland, Idaho, United States, 83619
Contact: Alison K. Conlin    503-215-2614    CanRsrchStudies@providence.org   
Principal Investigator: Alison K. Conlin         
Idaho Urologic Institute-Meridian Recruiting
Meridian, Idaho, United States, 83642
Contact: Christopher M. Reynolds    734-712-4673      
Principal Investigator: Christopher M. Reynolds         
Saint Luke's Mountain States Tumor Institute - Meridian Recruiting
Meridian, Idaho, United States, 83642
Contact: Alison K. Conlin    503-215-2614    CanRsrchStudies@providence.org   
Principal Investigator: Alison K. Conlin         
Saint Alphonsus Medical Center-Nampa Recruiting
Nampa, Idaho, United States, 83686
Contact: Christopher M. Reynolds    734-712-4673      
Principal Investigator: Christopher M. Reynolds         
Saint Luke's Mountain States Tumor Institute - Nampa Recruiting
Nampa, Idaho, United States, 83686
Contact: Alison K. Conlin    503-215-2614    CanRsrchStudies@providence.org   
Principal Investigator: Alison K. Conlin         
Kootenai Cancer Center Recruiting
Post Falls, Idaho, United States, 83854
Contact: Benjamin T. Marchello    800-648-6274      
Principal Investigator: Benjamin T. Marchello         
Kootenai Cancer Clinic Recruiting
Sandpoint, Idaho, United States, 83864
Contact: Benjamin T. Marchello    800-648-6274      
Principal Investigator: Benjamin T. Marchello         
Saint Luke's Mountain States Tumor Institute-Twin Falls Recruiting
Twin Falls, Idaho, United States, 83301
Contact: Alison K. Conlin    503-215-2614    CanRsrchStudies@providence.org   
Principal Investigator: Alison K. Conlin         
United States, Illinois
Rush - Copley Medical Center Recruiting
Aurora, Illinois, United States, 60504
Contact: Kendrith M. Rowland    800-446-5532      
Principal Investigator: Kendrith M. Rowland         
Saint Joseph Medical Center Suspended
Bloomington, Illinois, United States, 61701
Illinois CancerCare-Bloomington Recruiting
Bloomington, Illinois, United States, 61704
Contact: James L. Wade    217-876-4740    kcheek@dmhhs.org   
Principal Investigator: James L. Wade         
Illinois CancerCare-Canton Recruiting
Canton, Illinois, United States, 61520
Contact: James L. Wade    217-876-4740    kcheek@dmhhs.org   
Principal Investigator: James L. Wade         
Centralia Oncology Clinic Recruiting
Centralia, Illinois, United States, 62801
Contact: James L. Wade    217-876-4740    kcheek@dmhhs.org   
Principal Investigator: James L. Wade         
Northwestern University Recruiting
Chicago, Illinois, United States, 60611
Contact: Sunandana Chandra    312-695-1301    cancer@northwestern.edu   
Principal Investigator: Sunandana Chandra         
Carle on Vermilion Recruiting
Danville, Illinois, United States, 61832
Contact: Kendrith M. Rowland    800-446-5532      
Principal Investigator: Kendrith M. Rowland         
Cancer Care Center of Decatur Recruiting
Decatur, Illinois, United States, 62526
Contact: James L. Wade    217-876-4740    kcheek@dmhhs.org   
Principal Investigator: James L. Wade         
Decatur Memorial Hospital Recruiting
Decatur, Illinois, United States, 62526
Contact: James L. Wade    217-876-4740    kcheek@dmhhs.org   
Principal Investigator: James L. Wade         
Carle Physician Group-Effingham Recruiting
Effingham, Illinois, United States, 62401
Contact: Kendrith M. Rowland    800-446-5532      
Principal Investigator: Kendrith M. Rowland         
Crossroads Cancer Center Recruiting
Effingham, Illinois, United States, 62401
Contact: James L. Wade    217-876-4740    kcheek@dmhhs.org   
Principal Investigator: James L. Wade         
Illinois CancerCare-Eureka Recruiting
Eureka, Illinois, United States, 61530
Contact: James L. Wade    217-876-4740    kcheek@dmhhs.org   
Principal Investigator: James L. Wade         
NorthShore University HealthSystem-Evanston Hospital Recruiting
Evanston, Illinois, United States, 60201
Contact: Bruce E. Brockstein    847-570-2109      
Principal Investigator: Bruce E. Brockstein         
Illinois CancerCare-Galesburg Recruiting
Galesburg, Illinois, United States, 61401
Contact: James L. Wade    217-876-4740    kcheek@dmhhs.org   
Principal Investigator: James L. Wade         
Western Illinois Cancer Treatment Center Recruiting
Galesburg, Illinois, United States, 61401
Contact: James L. Wade    217-876-4740    kcheek@dmhhs.org   
Principal Investigator: James L. Wade         
Northwestern Medicine Cancer Center Delnor Recruiting
Geneva, Illinois, United States, 60134
Contact: John D. Ayers    630-315-1918    Claudine.Gamster@CadenceHealth.org   
Principal Investigator: John D. Ayers         
NorthShore University HealthSystem-Glenbrook Hospital Recruiting
Glenview, Illinois, United States, 60026
Contact: Bruce E. Brockstein    847-570-2109      
Principal Investigator: Bruce E. Brockstein         
NorthShore University HealthSystem-Highland Park Hospital Recruiting
Highland Park, Illinois, United States, 60035
Contact: Bruce E. Brockstein    847-570-2109      
Principal Investigator: Bruce E. Brockstein         
Illinois CancerCare-Macomb Recruiting
Macomb, Illinois, United States, 61455
Contact: James L. Wade    217-876-4740    kcheek@dmhhs.org   
Principal Investigator: James L. Wade         
Carle Physician Group-Mattoon/Charleston Recruiting
Mattoon, Illinois, United States, 61938
Contact: Kendrith M. Rowland    800-446-5532      
Principal Investigator: Kendrith M. Rowland         
Loyola University Medical Center Recruiting
Maywood, Illinois, United States, 60153
Contact: Joseph I. Clark    708-226-4357      
Principal Investigator: Joseph I. Clark         
Illinois CancerCare-Ottawa Clinic Recruiting
Ottawa, Illinois, United States, 61350
Contact: James L. Wade    217-876-4740    kcheek@dmhhs.org   
Principal Investigator: James L. Wade         
Illinois CancerCare-Pekin Recruiting
Pekin, Illinois, United States, 61554
Contact: James L. Wade    217-876-4740    kcheek@dmhhs.org   
Principal Investigator: James L. Wade         
OSF Saint Francis Radiation Oncology at Pekin Cancer Treatment Center Recruiting
Pekin, Illinois, United States, 61554
Contact: James L. Wade    217-876-4740    kcheek@dmhhs.org   
Principal Investigator: James L. Wade         
Methodist Medical Center of Illinois Recruiting
Peoria, Illinois, United States, 61603
Contact: James L. Wade    217-876-4740    kcheek@dmhhs.org   
Principal Investigator: James L. Wade         
Illinois CancerCare-Peoria Recruiting
Peoria, Illinois, United States, 61615
Contact: James L. Wade    217-876-4740    kcheek@dmhhs.org   
Principal Investigator: James L. Wade         
OSF Saint Francis Radiation Oncology at Peoria Cancer Center Recruiting
Peoria, Illinois, United States, 61615
Contact: James L. Wade    217-876-4740    kcheek@dmhhs.org   
Principal Investigator: James L. Wade         
OSF Saint Francis Medical Center Recruiting
Peoria, Illinois, United States, 61637
Contact: James L. Wade    217-876-4740    kcheek@dmhhs.org   
Principal Investigator: James L. Wade         
Illinois CancerCare-Peru Recruiting
Peru, Illinois, United States, 61354
Contact: James L. Wade    217-876-4740    kcheek@dmhhs.org   
Principal Investigator: James L. Wade         
Valley Radiation Oncology Recruiting
Peru, Illinois, United States, 61354
Contact: James L. Wade    217-876-4740    kcheek@dmhhs.org   
Principal Investigator: James L. Wade         
Southern Illinois University School of Medicine Recruiting
Springfield, Illinois, United States, 62702
Contact: James L. Wade    217-876-4740    kcheek@dmhhs.org   
Principal Investigator: James L. Wade         
Springfield Clinic Recruiting
Springfield, Illinois, United States, 62702
Contact: James L. Wade    217-876-4740    kcheek@dmhhs.org   
Principal Investigator: James L. Wade         
Memorial Medical Center Recruiting
Springfield, Illinois, United States, 62781
Contact: James L. Wade    217-876-4740    kcheek@dmhhs.org   
Principal Investigator: James L. Wade         
Cancer Care Specialists of Illinois-Swansea Recruiting
Swansea, Illinois, United States, 62226
Contact: James L. Wade    217-876-4740    kcheek@dmhhs.org   
Principal Investigator: James L. Wade         
Carle Cancer Center Recruiting
Urbana, Illinois, United States, 61801
Contact: Kendrith M. Rowland    800-446-5532      
Principal Investigator: Kendrith M. Rowland         
The Carle Foundation Hospital Recruiting
Urbana, Illinois, United States, 61801
Contact: Kendrith M. Rowland    800-446-5532      
Principal Investigator: Kendrith M. Rowland         
Northwestern Medicine Cancer Center Warrenville Recruiting
Warrenville, Illinois, United States, 60555
Contact: John D. Ayers    630-315-1918    Claudine.Gamster@CadenceHealth.org   
Principal Investigator: John D. Ayers         
Rush-Copley Healthcare Center Recruiting
Yorkville, Illinois, United States, 60560
Contact: Kendrith M. Rowland    800-446-5532      
Principal Investigator: Kendrith M. Rowland         
United States, Indiana
Indiana University/Melvin and Bren Simon Cancer Center Recruiting
Indianapolis, Indiana, United States, 46202
Contact: Theodore F. Logan    317-274-2552      
Principal Investigator: Theodore F. Logan         
Franciscan Health Indianapolis Recruiting
Indianapolis, Indiana, United States, 46237
Contact: Stephen E. Rubenstein    317-528-7060      
Principal Investigator: Stephen E. Rubenstein         
Kendrick Colon and Rectal Center-Indianapolis Recruiting
Indianapolis, Indiana, United States, 46237
Contact: Stephen E. Rubenstein    317-528-7060      
Principal Investigator: Stephen E. Rubenstein         
Franciscan Health Mooresville Recruiting
Mooresville, Indiana, United States, 46158
Contact: Stephen E. Rubenstein    317-528-7060      
Principal Investigator: Stephen E. Rubenstein         
United States, Iowa
Mary Greeley Medical Center Recruiting
Ames, Iowa, United States, 50010
Contact: Joseph J. Merchant    515-239-2621      
Principal Investigator: Joseph J. Merchant         
McFarland Clinic PC-William R Bliss Cancer Center Recruiting
Ames, Iowa, United States, 50010
Contact: Joseph J. Merchant    515-239-2621      
Principal Investigator: Joseph J. Merchant         
McFarland Clinic PC-Boone Recruiting
Boone, Iowa, United States, 50036
Contact: Joseph J. Merchant    515-239-2621      
Principal Investigator: Joseph J. Merchant         
Medical Oncology and Hematology Associates-West Des Moines Recruiting
Clive, Iowa, United States, 50325
Contact: Mehmet S. Copur    800-998-2119      
Principal Investigator: Mehmet S. Copur         
Mercy Cancer Center-West Lakes Recruiting
Clive, Iowa, United States, 50325
Contact: Mehmet S. Copur    800-998-2119      
Principal Investigator: Mehmet S. Copur         
Alegent Health Mercy Hospital Recruiting
Council Bluffs, Iowa, United States, 51503
Contact: Mehmet S. Copur    800-998-2119      
Principal Investigator: Mehmet S. Copur         
Greater Regional Medical Center Recruiting
Creston, Iowa, United States, 50801
Contact: Mehmet S. Copur    800-998-2119      
Principal Investigator: Mehmet S. Copur         
Medical Oncology and Hematology Associates-Laurel Recruiting
Des Moines, Iowa, United States, 50314
Contact: Mehmet S. Copur    800-998-2119      
Principal Investigator: Mehmet S. Copur         
Mercy Medical Center - Des Moines Recruiting
Des Moines, Iowa, United States, 50314
Contact: Mehmet S. Copur    800-998-2119      
Principal Investigator: Mehmet S. Copur         
McFarland Clinic PC-Trinity Cancer Center Recruiting
Fort Dodge, Iowa, United States, 50501
Contact: Joseph J. Merchant    515-239-2621      
Principal Investigator: Joseph J. Merchant         
McFarland Clinic PC-Jefferson Recruiting
Jefferson, Iowa, United States, 50129
Contact: Joseph J. Merchant    515-239-2621      
Principal Investigator: Joseph J. Merchant         
McFarland Clinic PC-Marshalltown Recruiting
Marshalltown, Iowa, United States, 50158
Contact: Joseph J. Merchant    515-239-2621      
Principal Investigator: Joseph J. Merchant         
Siouxland Regional Cancer Center Recruiting
Sioux City, Iowa, United States, 51101
Contact: Donald B. Wender    712-252-0088      
Principal Investigator: Donald B. Wender         
Mercy Medical Center-West Lakes Recruiting
West Des Moines, Iowa, United States, 50266
Contact: Mehmet S. Copur    800-998-2119      
Principal Investigator: Mehmet S. Copur         
United States, Kansas
Cancer Center of Kansas - Chanute Recruiting
Chanute, Kansas, United States, 66720
Contact: Shaker R. Dakhil    316-268-5374      
Principal Investigator: Shaker R. Dakhil         
Cancer Center of Kansas - Dodge City Recruiting
Dodge City, Kansas, United States, 67801
Contact: Shaker R. Dakhil    316-268-5374      
Principal Investigator: Shaker R. Dakhil         
Cancer Center of Kansas - El Dorado Recruiting
El Dorado, Kansas, United States, 67042
Contact: Shaker R. Dakhil    316-268-5374      
Principal Investigator: Shaker R. Dakhil         
Cancer Center of Kansas - Fort Scott Recruiting
Fort Scott, Kansas, United States, 66701
Contact: Shaker R. Dakhil    316-268-5374      
Principal Investigator: Shaker R. Dakhil         
Saint Catherine Hospital Recruiting
Garden City, Kansas, United States, 67846
Contact: Gary C. Doolittle    913-945-7552    ctnursenav@kumc.edu   
Principal Investigator: Gary C. Doolittle         
Heartland Cancer Center Recruiting
Great Bend, Kansas, United States, 67530
Contact: Gary C. Doolittle    913-945-7552    ctnursenav@kumc.edu   
Principal Investigator: Gary C. Doolittle         
Saint Rose Ambulatory and Surgery Center Suspended
Great Bend, Kansas, United States, 67530
Hays Medical Center Recruiting
Hays, Kansas, United States, 67601
Contact: Gary C. Doolittle    913-945-7552    ctnursenav@kumc.edu   
Principal Investigator: Gary C. Doolittle         
Cancer Center of Kansas-Independence Recruiting
Independence, Kansas, United States, 67301
Contact: Shaker R. Dakhil    316-268-5374      
Principal Investigator: Shaker R. Dakhil         
University of Kansas Cancer Center-West Recruiting
Kansas City, Kansas, United States, 66112
Contact: Gary C. Doolittle    913-945-7552    ctnursenav@kumc.edu   
Principal Investigator: Gary C. Doolittle         
University of Kansas Cancer Center Recruiting
Kansas City, Kansas, United States, 66160
Contact: Gary C. Doolittle    913-945-7552    ctnursenav@kumc.edu   
Principal Investigator: Gary C. Doolittle         
Cancer Center of Kansas-Kingman Recruiting
Kingman, Kansas, United States, 67068
Contact: Shaker R. Dakhil    316-268-5374      
Principal Investigator: Shaker R. Dakhil         
Lawrence Memorial Hospital Recruiting
Lawrence, Kansas, United States, 66044
Contact: Shaker R. Dakhil    316-268-5374      
Principal Investigator: Shaker R. Dakhil         
Cancer Center of Kansas-Liberal Recruiting
Liberal, Kansas, United States, 67905
Contact: Shaker R. Dakhil    316-268-5374      
Principal Investigator: Shaker R. Dakhil         
Cancer Center of Kansas - McPherson Recruiting
McPherson, Kansas, United States, 67460
Contact: Shaker R. Dakhil    316-268-5374      
Principal Investigator: Shaker R. Dakhil         
Cancer Center of Kansas - Newton Recruiting
Newton, Kansas, United States, 67114
Contact: Shaker R. Dakhil    316-268-5374      
Principal Investigator: Shaker R. Dakhil         
Olathe Medical Center Recruiting
Olathe, Kansas, United States, 66061
Contact: Gary C. Doolittle    913-945-7552    ctnursenav@kumc.edu   
Principal Investigator: Gary C. Doolittle         
University of Kansas Cancer Center-Overland Park Recruiting
Overland Park, Kansas, United States, 66210
Contact: Gary C. Doolittle    913-945-7552    ctnursenav@kumc.edu   
Principal Investigator: Gary C. Doolittle         
Cancer Center of Kansas - Parsons Recruiting
Parsons, Kansas, United States, 67357
Contact: Shaker R. Dakhil    316-268-5374      
Principal Investigator: Shaker R. Dakhil         
Cancer Center of Kansas - Pratt Recruiting
Pratt, Kansas, United States, 67124
Contact: Shaker R. Dakhil    316-268-5374      
Principal Investigator: Shaker R. Dakhil         
Cancer Center of Kansas - Salina Recruiting
Salina, Kansas, United States, 67401
Contact: Shaker R. Dakhil    316-268-5374      
Principal Investigator: Shaker R. Dakhil         
Salina Regional Health Center Recruiting
Salina, Kansas, United States, 67401
Contact: Gary C. Doolittle    913-945-7552    ctnursenav@kumc.edu   
Principal Investigator: Gary C. Doolittle         
Saint Francis Hospital and Medical Center - Topeka Recruiting
Topeka, Kansas, United States, 66606
Contact: Gary C. Doolittle    913-945-7552    ctnursenav@kumc.edu   
Principal Investigator: Gary C. Doolittle         
Cancer Center of Kansas - Wellington Recruiting
Wellington, Kansas, United States, 67152
Contact: Shaker R. Dakhil    316-268-5374      
Principal Investigator: Shaker R. Dakhil         
Associates In Womens Health Recruiting
Wichita, Kansas, United States, 67208
Contact: Shaker R. Dakhil    316-268-5374      
Principal Investigator: Shaker R. Dakhil         
Cancer Center of Kansas-Wichita Medical Arts Tower Recruiting
Wichita, Kansas, United States, 67208
Contact: Shaker R. Dakhil    316-268-5374      
Principal Investigator: Shaker R. Dakhil         
Cancer Center of Kansas - Wichita Recruiting
Wichita, Kansas, United States, 67214
Contact: Shaker R. Dakhil    316-268-5374      
Principal Investigator: Shaker R. Dakhil         
Via Christi Regional Medical Center Recruiting
Wichita, Kansas, United States, 67214
Contact: Shaker R. Dakhil    316-268-5374      
Principal Investigator: Shaker R. Dakhil         
Cancer Center of Kansas - Winfield Recruiting
Winfield, Kansas, United States, 67156
Contact: Shaker R. Dakhil    316-268-5374      
Principal Investigator: Shaker R. Dakhil         
United States, Kentucky
Flaget Memorial Hospital Recruiting
Bardstown, Kentucky, United States, 40004
Contact: Mehmet S. Copur    800-998-2119      
Principal Investigator: Mehmet S. Copur         
Commonwealth Cancer Center-Corbin Recruiting
Corbin, Kentucky, United States, 40701
Contact: Mehmet S. Copur    800-998-2119      
Principal Investigator: Mehmet S. Copur         
Oncology Hematology Care Inc-Crestview Suspended
Crestview Hills, Kentucky, United States, 41017
Saint Joseph Radiation Oncology Resource Center Recruiting
Lexington, Kentucky, United States, 40504
Contact: Mehmet S. Copur    800-998-2119      
Principal Investigator: Mehmet S. Copur         
Saint Joseph Hospital East Recruiting
Lexington, Kentucky, United States, 40509
Contact: Mehmet S. Copur    800-998-2119      
Principal Investigator: Mehmet S. Copur         
Jewish Hospital Recruiting
Louisville, Kentucky, United States, 40202
Contact: Mehmet S. Copur    800-998-2119      
Principal Investigator: Mehmet S. Copur         
The James Graham Brown Cancer Center at University of Louisville Recruiting
Louisville, Kentucky, United States, 40202
Contact: Jason A. Chesney    866-530-5516      
Principal Investigator: Jason A. Chesney         
Saints Mary and Elizabeth Hospital Recruiting
Louisville, Kentucky, United States, 40215
Contact: Mehmet S. Copur    800-998-2119      
Principal Investigator: Mehmet S. Copur         
Jewish Hospital Medical Center Northeast Recruiting
Louisville, Kentucky, United States, 40245
Contact: Mehmet S. Copur    800-998-2119      
Principal Investigator: Mehmet S. Copur         
Jewish Hospital Medical Center South Recruiting
Shepherdsville, Kentucky, United States, 40165
Contact: Mehmet S. Copur    800-998-2119      
Principal Investigator: Mehmet S. Copur         
United States, Louisiana
LSU Health Baton Rouge-North Clinic Suspended
Baton Rouge, Louisiana, United States, 70805
Louisiana Hematology Oncology Associates LLC Suspended
Baton Rouge, Louisiana, United States, 70809
Mary Bird Perkins Cancer Center Suspended
Baton Rouge, Louisiana, United States, 70809
Medical Oncology LLC Suspended
Baton Rouge, Louisiana, United States, 70809
Mary Bird Cancer Center/Saint Tammany Parish Suspended
Covington, Louisiana, United States, 70433
North Shore Hematology Oncology Associates Inc Recruiting
Covington, Louisiana, United States, 70433
Contact: David S. Hanson    225-215-1353    clinicalresearch@marybird.com   
Principal Investigator: David S. Hanson         
Mary Bird Perkins Cancer Center/Terrebonne General Medical Center Suspended
Houma, Louisiana, United States, 70360
Oncology Center of The South Incorporated Recruiting
Houma, Louisiana, United States, 70360
Contact: David S. Hanson    225-215-1353    clinicalresearch@marybird.com   
Principal Investigator: David S. Hanson         
University Health-Conway Recruiting
Monroe, Louisiana, United States, 71202
Contact: Srinivas S. Devarakonda    318-813-1412      
Principal Investigator: Srinivas S. Devarakonda         
Ochsner Medical Center Jefferson Recruiting
New Orleans, Louisiana, United States, 70121
Contact: Furhan Yunus    504-842-3708      
Principal Investigator: Furhan Yunus         
Louisiana State University Health Sciences Center Shreveport Recruiting
Shreveport, Louisiana, United States, 71103
Contact: Srinivas S. Devarakonda    318-813-1412      
Principal Investigator: Srinivas S. Devarakonda         
United States, Maryland
Greater Baltimore Medical Center Recruiting
Baltimore, Maryland, United States, 21204
Contact: Mei Tang    443-849-3706      
Principal Investigator: Mei Tang         
Saint Agnes Hospital Recruiting
Baltimore, Maryland, United States, 21229
Contact: Carole B. Miller    410-368-2910      
Principal Investigator: Carole B. Miller         
MedStar Franklin Square Medical Center/Weinberg Cancer Institute Recruiting
Baltimore, Maryland, United States, 21237
Contact: Michael B. Atkins    202-444-2223      
Principal Investigator: Michael B. Atkins         
Frederick Memorial Hospital Recruiting
Frederick, Maryland, United States, 21701
Contact: Mark G. Goldstein    240-566-3584    clinicaltrials@fmh.org   
Principal Investigator: Mark G. Goldstein         
United States, Massachusetts
University of Massachusetts Medical School Recruiting
Worcester, Massachusetts, United States, 01655
Contact: Tasneem Ali    508-856-3216    cancer.research@umassmed.edu   
Principal Investigator: Tasneem Ali         
United States, Michigan
Hickman Cancer Center Recruiting
Adrian, Michigan, United States, 49221
Contact: Rex B. Mowat    800-444-3561      
Principal Investigator: Rex B. Mowat         
Saint Joseph Mercy Hospital Recruiting
Ann Arbor, Michigan, United States, 48106-0995
Contact: Christopher M. Reynolds    734-712-4673      
Principal Investigator: Christopher M. Reynolds         
University of Michigan Comprehensive Cancer Center Recruiting
Ann Arbor, Michigan, United States, 48109
Contact: Leslie A. Fecher    800-865-1125      
Principal Investigator: Leslie A. Fecher         
Bronson Battle Creek Recruiting
Battle Creek, Michigan, United States, 49017
Contact: Kathleen J. Yost    616-391-1230    crcwm-regulatory@crcwm.org   
Principal Investigator: Kathleen J. Yost         
IHA Hematology Oncology Consultants-Brighton Recruiting
Brighton, Michigan, United States, 48114
Contact: Christopher M. Reynolds    734-712-4673      
Principal Investigator: Christopher M. Reynolds         
Saint Joseph Mercy Brighton Recruiting
Brighton, Michigan, United States, 48114
Contact: Christopher M. Reynolds    734-712-4673      
Principal Investigator: Christopher M. Reynolds         
IHA Hematology Oncology Consultants-Canton Recruiting
Canton, Michigan, United States, 48188
Contact: Christopher M. Reynolds    734-712-4673      
Principal Investigator: Christopher M. Reynolds         
Saint Joseph Mercy Canton Health Center Recruiting
Canton, Michigan, United States, 48188
Contact: Christopher M. Reynolds    734-712-4673      
Principal Investigator: Christopher M. Reynolds         
Caro Cancer Center Recruiting
Caro, Michigan, United States, 48723
Contact: Christopher M. Reynolds    734-712-4673      
Principal Investigator: Christopher M. Reynolds         
IHA Hematology Oncology Consultants-Chelsea Recruiting
Chelsea, Michigan, United States, 48118
Contact: Christopher M. Reynolds    734-712-4673      
Principal Investigator: Christopher M. Reynolds         
Saint Joseph Mercy Chelsea Recruiting
Chelsea, Michigan, United States, 48118
Contact: Christopher M. Reynolds    734-712-4673      
Principal Investigator: Christopher M. Reynolds         
Hematology Oncology Consultants-Clarkston Recruiting
Clarkston, Michigan, United States, 48346
Contact: Christopher M. Reynolds    734-712-4673      
Principal Investigator: Christopher M. Reynolds         
Newland Medical Associates-Clarkston Recruiting
Clarkston, Michigan, United States, 48346
Contact: Christopher M. Reynolds    734-712-4673      
Principal Investigator: Christopher M. Reynolds         
Beaumont Hospital-Dearborn Recruiting
Dearborn, Michigan, United States, 48124
Contact: Christopher M. Reynolds    734-712-4673      
Principal Investigator: Christopher M. Reynolds         
Wayne State University/Karmanos Cancer Institute Recruiting
Detroit, Michigan, United States, 48201
Contact: Lawrence E. Flaherty    313-576-9363      
Principal Investigator: Lawrence E. Flaherty         
Saint John Hospital and Medical Center Recruiting
Detroit, Michigan, United States, 48236
Contact: Christopher M. Reynolds    734-712-4673      
Principal Investigator: Christopher M. Reynolds         
Great Lakes Cancer Management Specialists-Doctors Park Recruiting
East China Township, Michigan, United States, 48054
Contact: Christopher M. Reynolds    734-712-4673      
Principal Investigator: Christopher M. Reynolds         
Green Bay Oncology - Escanaba Recruiting
Escanaba, Michigan, United States, 49829
Contact: Brian L. Burnette    920-433-8889      
Principal Investigator: Brian L. Burnette         
Hurley Medical Center Recruiting
Flint, Michigan, United States, 48502
Contact: Christopher M. Reynolds    734-712-4673      
Principal Investigator: Christopher M. Reynolds         
Genesee Cancer and Blood Disease Treatment Center Recruiting
Flint, Michigan, United States, 48503
Contact: Christopher M. Reynolds    734-712-4673      
Principal Investigator: Christopher M. Reynolds         
Genesee Hematology Oncology PC Recruiting
Flint, Michigan, United States, 48503
Contact: Christopher M. Reynolds    734-712-4673      
Principal Investigator: Christopher M. Reynolds         
Genesys Hurley Cancer Institute Recruiting
Flint, Michigan, United States, 48503
Contact: Christopher M. Reynolds    734-712-4673      
Principal Investigator: Christopher M. Reynolds         
Mercy Health Saint Mary's Recruiting
Grand Rapids, Michigan, United States, 49503
Contact: Kathleen J. Yost    616-391-1230    crcwm-regulatory@crcwm.org   
Principal Investigator: Kathleen J. Yost         
Spectrum Health at Butterworth Campus Recruiting
Grand Rapids, Michigan, United States, 49503
Contact: Kathleen J. Yost    616-391-1230    crcwm-regulatory@crcwm.org   
Principal Investigator: Kathleen J. Yost         
Great Lakes Cancer Management Specialists-Van Elslander Cancer Center Recruiting
Grosse Pointe Woods, Michigan, United States, 48236
Contact: Christopher M. Reynolds    734-712-4673      
Principal Investigator: Christopher M. Reynolds         
Lymphoma Clinic of Michigan Recruiting
Grosse Pointe Woods, Michigan, United States, 48236
Contact: Christopher M. Reynolds    734-712-4673      
Principal Investigator: Christopher M. Reynolds         
Michigan Breast Specialists-Grosse Pointe Woods Recruiting
Grosse Pointe Woods, Michigan, United States, 48236
Contact: Christopher M. Reynolds    734-712-4673      
Principal Investigator: Christopher M. Reynolds         
Allegiance Health Recruiting
Jackson, Michigan, United States, 49201
Contact: Christopher M. Reynolds    734-712-4673      
Principal Investigator: Christopher M. Reynolds         
Borgess Medical Center Recruiting
Kalamazoo, Michigan, United States, 49001
Contact: Kathleen J. Yost    616-391-1230    crcwm-regulatory@crcwm.org   
Principal Investigator: Kathleen J. Yost         
West Michigan Cancer Center Recruiting
Kalamazoo, Michigan, United States, 49007
Contact: Kathleen J. Yost    616-391-1230    crcwm-regulatory@crcwm.org   
Principal Investigator: Kathleen J. Yost         
Sparrow Hospital Recruiting
Lansing, Michigan, United States, 48912
Contact: Christopher M. Reynolds    734-712-4673      
Principal Investigator: Christopher M. Reynolds         
Hope Cancer Clinic Recruiting
Livonia, Michigan, United States, 48154
Contact: Christopher M. Reynolds    734-712-4673      
Principal Investigator: Christopher M. Reynolds         
Saint Mary Mercy Hospital Recruiting
Livonia, Michigan, United States, 48154
Contact: Christopher M. Reynolds    734-712-4673      
Principal Investigator: Christopher M. Reynolds         
Hematology Oncology Associates East PC Recruiting
Macomb, Michigan, United States, 48044
Contact: Christopher M. Reynolds    734-712-4673      
Principal Investigator: Christopher M. Reynolds         
Michigan Breast Specialists-Macomb Township Recruiting
Macomb, Michigan, United States, 48044
Contact: Christopher M. Reynolds    734-712-4673      
Principal Investigator: Christopher M. Reynolds         
Toledo Clinic Cancer Centers-Monroe Recruiting
Monroe, Michigan, United States, 48162
Contact: Rex B. Mowat    800-444-3561      
Principal Investigator: Rex B. Mowat         
Mercy Health Mercy Campus Recruiting
Muskegon, Michigan, United States, 49444
Contact: Kathleen J. Yost    616-391-1230    crcwm-regulatory@crcwm.org   
Principal Investigator: Kathleen J. Yost         
21st Century Oncology-Pontiac Recruiting
Pontiac, Michigan, United States, 48341
Contact: Christopher M. Reynolds    734-712-4673      
Principal Investigator: Christopher M. Reynolds         
Hope Cancer Center Recruiting
Pontiac, Michigan, United States, 48341
Contact: Christopher M. Reynolds    734-712-4673      
Principal Investigator: Christopher M. Reynolds         
Newland Medical Associates-Pontiac Recruiting
Pontiac, Michigan, United States, 48341
Contact: Christopher M. Reynolds    734-712-4673      
Principal Investigator: Christopher M. Reynolds         
Saint Joseph Mercy Oakland Recruiting
Pontiac, Michigan, United States, 48341
Contact: Christopher M. Reynolds    734-712-4673      
Principal Investigator: Christopher M. Reynolds         
Spectrum Health Reed City Hospital Recruiting
Reed City, Michigan, United States, 49677
Contact: Kathleen J. Yost    616-391-1230    crcwm-regulatory@crcwm.org   
Principal Investigator: Kathleen J. Yost         
Great Lakes Cancer Management Specialists-Rochester Hills Recruiting
Rochester Hills, Michigan, United States, 48309
Contact: Christopher M. Reynolds    734-712-4673      
Principal Investigator: Christopher M. Reynolds         
Saint Mary's of Michigan Recruiting
Saginaw, Michigan, United States, 48601
Contact: Christopher M. Reynolds    734-712-4673      
Principal Investigator: Christopher M. Reynolds         
Oncology Hematology Associates of Saginaw Valley PC Recruiting
Saginaw, Michigan, United States, 48604
Contact: Christopher M. Reynolds    734-712-4673      
Principal Investigator: Christopher M. Reynolds         
Bhadresh Nayak MD PC-Sterling Heights Recruiting
Sterling Heights, Michigan, United States, 48312
Contact: Christopher M. Reynolds    734-712-4673      
Principal Investigator: Christopher M. Reynolds         
Munson Medical Center Recruiting
Traverse City, Michigan, United States, 49684
Contact: Kathleen J. Yost    616-391-1230    crcwm-regulatory@crcwm.org   
Principal Investigator: Kathleen J. Yost         
Great Lakes Cancer Management Specialists-Macomb Professional Building Recruiting
Warren, Michigan, United States, 48093
Contact: Christopher M. Reynolds    734-712-4673      
Principal Investigator: Christopher M. Reynolds         
Macomb Hematology Oncology PC Recruiting
Warren, Michigan, United States, 48093
Contact: Christopher M. Reynolds    734-712-4673      
Principal Investigator: Christopher M. Reynolds         
Michigan Breast Specialists-Warren Recruiting
Warren, Michigan, United States, 48093
Contact: Christopher M. Reynolds    734-712-4673      
Principal Investigator: Christopher M. Reynolds         
Saint John Macomb-Oakland Hospital Recruiting
Warren, Michigan, United States, 48093
Contact: Christopher M. Reynolds    734-712-4673      
Principal Investigator: Christopher M. Reynolds         
Saint Mary's Oncology/Hematology Associates of West Branch Recruiting
West Branch, Michigan, United States, 48661
Contact: Christopher M. Reynolds    734-712-4673      
Principal Investigator: Christopher M. Reynolds         
Huron Gastroenterology PC Recruiting
Ypsilanti, Michigan, United States, 48106
Contact: Christopher M. Reynolds    734-712-4673      
Principal Investigator: Christopher M. Reynolds         
IHA Hematology Oncology Consultants-Ann Arbor Recruiting
Ypsilanti, Michigan, United States, 48197
Contact: Christopher M. Reynolds    734-712-4673      
Principal Investigator: Christopher M. Reynolds         
United States, Minnesota
Sanford Clinic North-Bemidgi Recruiting
Bemidji, Minnesota, United States, 56601
Contact: Preston D. Steen    701-234-6161      
Principal Investigator: Preston D. Steen         
Essentia Health Saint Joseph's Medical Center Recruiting
Brainerd, Minnesota, United States, 56401
Contact: Bret E. Friday    888-203-7267      
Principal Investigator: Bret E. Friday         
Mercy Hospital Recruiting
Coon Rapids, Minnesota, United States, 55433
Contact: David M. King    952-993-1517    mmcorc@healthpartners.com   
Principal Investigator: David M. King         
Essentia Health Cancer Center Recruiting
Duluth, Minnesota, United States, 55805
Contact: Bret E. Friday    888-203-7267      
Principal Investigator: Bret E. Friday         
Essentia Health Saint Mary's Medical Center Recruiting
Duluth, Minnesota, United States, 55805
Contact: Bret E. Friday    888-203-7267      
Principal Investigator: Bret E. Friday         
Miller-Dwan Hospital Recruiting
Duluth, Minnesota, United States, 55805
Contact: Bret E. Friday    888-203-7267      
Principal Investigator: Bret E. Friday         
Fairview-Southdale Hospital Recruiting
Edina, Minnesota, United States, 55435
Contact: David M. King    952-993-1517    mmcorc@healthpartners.com   
Principal Investigator: David M. King         
Lake Region Healthcare Corporation-Cancer Care Recruiting
Fergus Falls, Minnesota, United States, 56537
Contact: Bret E. Friday    888-203-7267      
Principal Investigator: Bret E. Friday         
Unity Hospital Recruiting
Fridley, Minnesota, United States, 55432
Contact: David M. King    952-993-1517    mmcorc@healthpartners.com   
Principal Investigator: David M. King         
Minnesota Oncology Hematology PA-Maplewood Recruiting
Maplewood, Minnesota, United States, 55109
Contact: David M. King    952-993-1517    mmcorc@healthpartners.com   
Principal Investigator: David M. King         
Abbott-Northwestern Hospital Recruiting
Minneapolis, Minnesota, United States, 55407
Contact: David M. King    952-993-1517    mmcorc@healthpartners.com   
Principal Investigator: David M. King         
Hennepin County Medical Center Recruiting
Minneapolis, Minnesota, United States, 55415
Contact: David M. King    952-993-1517    mmcorc@healthpartners.com   
Principal Investigator: David M. King         
Health Partners Inc Recruiting
Minneapolis, Minnesota, United States, 55454
Contact: David M. King    952-993-1517    mmcorc@healthpartners.com   
Principal Investigator: David M. King         
North Memorial Medical Health Center Recruiting
Robbinsdale, Minnesota, United States, 55422
Contact: David M. King    952-993-1517    mmcorc@healthpartners.com   
Principal Investigator: David M. King         
Regions Hospital Recruiting
Saint Paul, Minnesota, United States, 55101
Contact: David M. King    952-993-1517    mmcorc@healthpartners.com   
Principal Investigator: David M. King         
United Hospital Recruiting
Saint Paul, Minnesota, United States, 55102
Contact: David M. King    952-993-1517    mmcorc@healthpartners.com   
Principal Investigator: David M. King         
Saint Francis Regional Medical Center Recruiting
Shakopee, Minnesota, United States, 55379
Contact: David M. King    952-993-1517    mmcorc@healthpartners.com   
Principal Investigator: David M. King         
Minnesota Oncology Hematology PA-Woodbury Recruiting
Woodbury, Minnesota, United States, 55125
Contact: David M. King    952-993-1517    mmcorc@healthpartners.com   
Principal Investigator: David M. King         
United States, Mississippi
University of Mississippi Medical Center Recruiting
Jackson, Mississippi, United States, 39216
Contact: Natale T. Sheehan    601-815-6700      
Principal Investigator: Natale T. Sheehan         
United States, Missouri
Parkland Health Center-Bonne Terre Recruiting
Bonne Terre, Missouri, United States, 63628
Contact: James L. Wade    217-876-4740    kcheek@dmhhs.org   
Principal Investigator: James L. Wade         
Saint Francis Medical Center Recruiting
Cape Girardeau, Missouri, United States, 63703
Contact: James L. Wade    217-876-4740    kcheek@dmhhs.org   
Principal Investigator: James L. Wade         
Southeast Cancer Center Recruiting
Cape Girardeau, Missouri, United States, 63703
Contact: James L. Wade    217-876-4740    kcheek@dmhhs.org   
Principal Investigator: James L. Wade         
Capital Region Medical Center-Goldschmidt Cancer Center Recruiting
Jefferson City, Missouri, United States, 65109
Contact: James L. Wade    217-876-4740    kcheek@dmhhs.org   
Principal Investigator: James L. Wade         
Truman Medical Center Recruiting
Kansas City, Missouri, United States, 64108
Contact: Gary C. Doolittle    913-945-7552    ctnursenav@kumc.edu   
Principal Investigator: Gary C. Doolittle         
The University of Kansas Cancer Center-South Suspended
Kansas City, Missouri, United States, 64131
The University of Kansas Cancer Center-Lee's Summit Suspended
Lee's Summit, Missouri, United States, 64064
Heartland Regional Medical Center Recruiting
Saint Joseph, Missouri, United States, 64506
Contact: Rakesh Gaur    913-948-5588    aroland@kccop.org   
Principal Investigator: Rakesh Gaur         
Missouri Baptist Medical Center Recruiting
Saint Louis, Missouri, United States, 63131
Contact: James L. Wade    217-876-4740    kcheek@dmhhs.org   
Principal Investigator: James L. Wade         
Sainte Genevieve County Memorial Hospital Recruiting
Sainte Genevieve, Missouri, United States, 63670
Contact: James L. Wade    217-876-4740    kcheek@dmhhs.org   
Principal Investigator: James L. Wade         
Mercy Hospital Springfield Recruiting
Springfield, Missouri, United States, 65804
Contact: Jay W. Carlson    800-821-7532      
Principal Investigator: Jay W. Carlson         
CoxHealth South Hospital Recruiting
Springfield, Missouri, United States, 65807
Contact: Jay W. Carlson    800-821-7532      
Principal Investigator: Jay W. Carlson         
Missouri Baptist Sullivan Hospital Recruiting
Sullivan, Missouri, United States, 63080
Contact: James L. Wade    217-876-4740    kcheek@dmhhs.org   
Principal Investigator: James L. Wade         
Missouri Baptist Outpatient Center-Sunset Hills Recruiting
Sunset Hills, Missouri, United States, 63127
Contact: James L. Wade    217-876-4740    kcheek@dmhhs.org   
Principal Investigator: James L. Wade         
United States, Montana
Bozeman Deaconess Hospital Recruiting
Bozeman, Montana, United States, 59715
Contact: Benjamin T. Marchello    800-648-6274      
Principal Investigator: Benjamin T. Marchello         
Benefis Healthcare- Sletten Cancer Institute Recruiting
Great Falls, Montana, United States, 59405
Contact: Benjamin T. Marchello    800-648-6274      
Principal Investigator: Benjamin T. Marchello         
Saint Peter's Community Hospital Suspended
Helena, Montana, United States, 59601
Kalispell Regional Medical Center Suspended
Kalispell, Montana, United States, 59901
Saint Patrick Hospital - Community Hospital Recruiting
Missoula, Montana, United States, 59802
Contact: Alison K. Conlin    503-215-2614    CanRsrchStudies@providence.org   
Principal Investigator: Alison K. Conlin         
United States, Nebraska
CHI Health Saint Francis Recruiting
Grand Island, Nebraska, United States, 68803
Contact: Mehmet S. Copur    800-998-2119      
Principal Investigator: Mehmet S. Copur         
Heartland Hematology and Oncology Recruiting
Kearney, Nebraska, United States, 68845
Contact: Mehmet S. Copur    800-998-2119      
Principal Investigator: Mehmet S. Copur         
CHI Health Good Samaritan Recruiting
Kearney, Nebraska, United States, 68847
Contact: Mehmet S. Copur    800-998-2119      
Principal Investigator: Mehmet S. Copur         
Saint Elizabeth Regional Medical Center Recruiting
Lincoln, Nebraska, United States, 68510
Contact: Mehmet S. Copur    800-998-2119      
Principal Investigator: Mehmet S. Copur         
Great Plains Regional Medical Center Recruiting
North Platte, Nebraska, United States, 69103
Contact: Gamini S. Soori    402-393-3110      
Principal Investigator: Gamini S. Soori         
Nebraska Methodist Hospital Recruiting
Omaha, Nebraska, United States, 68114
Contact: Ralph J. Hauke    402-393-3110      
Principal Investigator: Ralph J. Hauke         
Alegent Health Immanuel Medical Center Recruiting
Omaha, Nebraska, United States, 68122
Contact: Mehmet S. Copur    800-998-2119      
Principal Investigator: Mehmet S. Copur         
Hemotology and Oncology Consultants PC Recruiting
Omaha, Nebraska, United States, 68122
Contact: Mehmet S. Copur    800-998-2119      
Principal Investigator: Mehmet S. Copur         
Alegent Health Bergan Mercy Medical Center Recruiting
Omaha, Nebraska, United States, 68124
Contact: Mehmet S. Copur    800-998-2119      
Principal Investigator: Mehmet S. Copur         
Alegent Health Lakeside Hospital Recruiting
Omaha, Nebraska, United States, 68130
Contact: Mehmet S. Copur    800-998-2119      
Principal Investigator: Mehmet S. Copur         
Creighton University Medical Center Recruiting
Omaha, Nebraska, United States, 68131
Contact: Mehmet S. Copur    800-998-2119      
Principal Investigator: Mehmet S. Copur         
University of Nebraska Medical Center Recruiting
Omaha, Nebraska, United States, 68198
Contact: Alissa S. Marr    402-559-6941    unmcrsa@unmc.edu   
Principal Investigator: Alissa S. Marr         
Midlands Community Hospital Recruiting
Papillion, Nebraska, United States, 68046
Contact: Mehmet S. Copur    800-998-2119      
Principal Investigator: Mehmet S. Copur         
United States, Nevada
Cancer and Blood Specialists-Henderson Recruiting
Henderson, Nevada, United States, 89052
Contact: John A. Ellerton    702-384-0013      
Principal Investigator: John A. Ellerton         
Comprehensive Cancer Centers of Nevada - Henderson Recruiting
Henderson, Nevada, United States, 89052
Contact: John A. Ellerton    702-384-0013      
Principal Investigator: John A. Ellerton         
Comprehensive Cancer Centers of Nevada-Southeast Henderson Recruiting
Henderson, Nevada, United States, 89074
Contact: John A. Ellerton    702-384-0013      
Principal Investigator: John A. Ellerton         
University Medical Center of Southern Nevada Recruiting
Las Vegas, Nevada, United States, 89102
Contact: John A. Ellerton    702-384-0013      
Principal Investigator: John A. Ellerton         
Cancer and Blood Specialists-Shadow Recruiting
Las Vegas, Nevada, United States, 89106
Contact: John A. Ellerton    702-384-0013      
Principal Investigator: John A. Ellerton         
Ann M Wierman MD LTD Recruiting
Las Vegas, Nevada, United States, 89128
Contact: John A. Ellerton    702-384-0013      
Principal Investigator: John A. Ellerton         
Cancer and Blood Specialists-Tenaya Recruiting
Las Vegas, Nevada, United States, 89128
Contact: John A. Ellerton    702-384-0013      
Principal Investigator: John A. Ellerton         
Comprehensive Cancer Centers of Nevada - Northwest Recruiting
Las Vegas, Nevada, United States, 89128
Contact: John A. Ellerton    702-384-0013      
Principal Investigator: John A. Ellerton         
Comprehensive Cancer Centers of Nevada-Summerlin Recruiting
Las Vegas, Nevada, United States, 89144
Contact: John A. Ellerton    702-384-0013      
Principal Investigator: John A. Ellerton         
Comprehensive Cancer Centers of Nevada Recruiting
Las Vegas, Nevada, United States, 89148
Contact: John A. Ellerton    702-384-0013      
Principal Investigator: John A. Ellerton         
Nevada Cancer Specialists-Fort Apache Recruiting
Las Vegas, Nevada, United States, 89148
Contact: John A. Ellerton    702-384-0013      
Principal Investigator: John A. Ellerton         
Comprehensive Cancer Centers of Nevada - Central Valley Recruiting
Las Vegas, Nevada, United States, 89169
Contact: John A. Ellerton    702-384-0013      
Principal Investigator: John A. Ellerton         
Renown Regional Medical Center Recruiting
Reno, Nevada, United States, 89502
Contact: John A. Ellerton    702-384-0013      
Principal Investigator: John A. Ellerton         
Saint Mary's Regional Medical Center Recruiting
Reno, Nevada, United States, 89503
Contact: John A. Ellerton    702-384-0013      
Principal Investigator: John A. Ellerton         
United States, New Jersey
Hackensack University Medical Center Recruiting
Hackensack, New Jersey, United States, 07601
Contact: Donna T. McNamara    201-996-2879      
Principal Investigator: Donna T. McNamara         
United States, New Mexico
University of New Mexico Cancer Center Recruiting
Albuquerque, New Mexico, United States, 87102
Contact: Ian Rabinowitz    505-925-0366    LByatt@nmcca.org   
Principal Investigator: Ian Rabinowitz         
New Mexico Oncology Hematology Consultants Recruiting
Albuquerque, New Mexico, United States, 87109
Contact: Ian Rabinowitz    505-925-0366    LByatt@nmcca.org   
Principal Investigator: Ian Rabinowitz         
Presbyterian Kaseman Hospital Suspended
Albuquerque, New Mexico, United States, 87110
Memorial Medical Center - Las Cruces Recruiting
Las Cruces, New Mexico, United States, 88011
Contact: Ian Rabinowitz    505-925-0366    LByatt@nmcca.org   
Principal Investigator: Ian Rabinowitz         
Presbyterian Rust Medical Center/Jorgensen Cancer Center Recruiting
Rio Rancho, New Mexico, United States, 87124
Contact: Ian Rabinowitz    505-925-0366    LByatt@nmcca.org   
Principal Investigator: Ian Rabinowitz         
United States, New York
New York Oncology Hematology PC -Albany Medical Center Recruiting
Albany, New York, United States, 12208
Contact: Charles H. Weissman    518-489-3612    gerryann.currier@usoncology.com   
Principal Investigator: Charles H. Weissman         
Roswell Park Cancer Institute Recruiting
Buffalo, New York, United States, 14263
Contact: Marc S. Ernstoff    877-275-7724      
Principal Investigator: Marc S. Ernstoff         
Mary Imogene Bassett Hospital Recruiting
Cooperstown, New York, United States, 13326
Contact: Eric Bravin    607-547-3073    diana.crean@bassett.org   
Principal Investigator: Eric Bravin         
University of Rochester Recruiting
Rochester, New York, United States, 14642
Contact: Paul M. Barr    585-275-5830      
Principal Investigator: Paul M. Barr         
Stony Brook University Medical Center Recruiting
Stony Brook, New York, United States, 11794
Contact: Andrzej P. Kudelka    800-862-2215      
Principal Investigator: Andrzej P. Kudelka         
United States, North Carolina
Asheville Hematology-Oncology Associates Suspended
Asheville, North Carolina, United States, 28803
Southeastern Medical Oncology Center-Clinton Recruiting
Clinton, North Carolina, United States, 28328
Contact: James N. Atkins    919-580-0000      
Principal Investigator: James N. Atkins         
Southeastern Medical Oncology Center-Goldsboro Recruiting
Goldsboro, North Carolina, United States, 27534
Contact: James N. Atkins    919-580-0000      
Principal Investigator: James N. Atkins         
Wayne Memorial Hospital Recruiting
Goldsboro, North Carolina, United States, 27534
Contact: James N. Atkins    919-580-0000      
Principal Investigator: James N. Atkins         
Margaret R Pardee Memorial Hospital Recruiting
Hendersonville, North Carolina, United States, 28791
Contact: James E. Radford    828-696-4716      
Principal Investigator: James E. Radford         
Onslow Memorial Hospital Recruiting
Jacksonville, North Carolina, United States, 28546
Contact: James N. Atkins    919-580-0000      
Principal Investigator: James N. Atkins         
Southeastern Medical Oncology Center-Jacksonville Recruiting
Jacksonville, North Carolina, United States, 28546
Contact: James N. Atkins    919-580-0000      
Principal Investigator: James N. Atkins         
Kinston Medical Specialists PA Recruiting
Kinston, North Carolina, United States, 28501
Contact: Peter R. Watson    252-559-2200      
Principal Investigator: Peter R. Watson         
Southeastern Medical Oncology Center-Wilson Recruiting
Wilson, North Carolina, United States, 27893
Contact: James N. Atkins    919-580-0000      
Principal Investigator: James N. Atkins         
Southeast Clinical Oncology Research (SCOR) Consortium NCORP Recruiting
Winston-Salem, North Carolina, United States, 27104
Contact: Asheesh Shipstone    423-578-8538      
Principal Investigator: Asheesh Shipstone         
United States, North Dakota
Sanford Bismarck Medical Center Recruiting
Bismarck, North Dakota, United States, 58501
Contact: Preston D. Steen    701-234-6161      
Principal Investigator: Preston D. Steen         
Essentia Health Cancer Center-South University Clinic Recruiting
Fargo, North Dakota, United States, 58103
Contact: Bret E. Friday    888-203-7267      
Principal Investigator: Bret E. Friday         
Roger Maris Cancer Center Recruiting
Fargo, North Dakota, United States, 58122
Contact: Preston D. Steen    701-234-6161      
Principal Investigator: Preston D. Steen         
Sanford Clinic North-Fargo Recruiting
Fargo, North Dakota, United States, 58122
Contact: Preston D. Steen    701-234-6161      
Principal Investigator: Preston D. Steen         
Sanford Medical Center-Fargo Recruiting
Fargo, North Dakota, United States, 58122
Contact: Preston D. Steen    701-234-6161      
Principal Investigator: Preston D. Steen         
United States, Ohio
UHHS-Chagrin Highlands Medical Center Recruiting
Beachwood, Ohio, United States, 44122
Contact: Henry B. Koon    800-641-2422      
Principal Investigator: Henry B. Koon         
Dayton Physicians LLC-Miami Valley South Recruiting
Centerville, Ohio, United States, 45459
Contact: Howard M. Gross    937-775-1350    som_dcop@wright.edu   
Principal Investigator: Howard M. Gross         
Miami Valley Hospital South Recruiting
Centerville, Ohio, United States, 45459
Contact: Howard M. Gross    937-775-1350    som_dcop@wright.edu   
Principal Investigator: Howard M. Gross         
Oncology Hematology Care Inc-Eden Park Suspended
Cincinnati, Ohio, United States, 45202
Oncology Hematology Care Inc-Mercy West Suspended
Cincinnati, Ohio, United States, 45211
University of Cincinnati/Barrett Cancer Center Recruiting
Cincinnati, Ohio, United States, 45219
Contact: Nagla Abdel Karim    513-558-4553    uchealthnews@uc.edu   
Principal Investigator: Nagla Abdel Karim         
Good Samaritan Hospital - Cincinnati Recruiting
Cincinnati, Ohio, United States, 45220
Contact: Mehmet S. Copur    800-998-2119      
Principal Investigator: Mehmet S. Copur         
Oncology Hematology Care Inc - Anderson Suspended
Cincinnati, Ohio, United States, 45230
Oncology Hematology Care Inc-Kenwood Recruiting
Cincinnati, Ohio, United States, 45236
Contact: Howard M. Gross    937-775-1350    som_dcop@wright.edu   
Principal Investigator: Howard M. Gross         
Bethesda North Hospital Recruiting
Cincinnati, Ohio, United States, 45242
Contact: Mehmet S. Copur    800-998-2119      
Principal Investigator: Mehmet S. Copur         
Oncology Hematology Care Inc-Blue Ash Suspended
Cincinnati, Ohio, United States, 45242
TriHealth Cancer Institute-Westside Recruiting
Cincinnati, Ohio, United States, 45247
Contact: Mehmet S. Copur    800-998-2119      
Principal Investigator: Mehmet S. Copur         
TriHealth Cancer Institute-Anderson Recruiting
Cincinnati, Ohio, United States, 45255
Contact: Mehmet S. Copur    800-998-2119      
Principal Investigator: Mehmet S. Copur         
Case Western Reserve University Recruiting
Cleveland, Ohio, United States, 44106
Contact: Henry B. Koon    800-641-2422      
Principal Investigator: Henry B. Koon         
MetroHealth Medical Center Recruiting
Cleveland, Ohio, United States, 44109
Contact: Bruce J. Averbook    216-778-8526    kbauchens@metrohealth.org   
Principal Investigator: Bruce J. Averbook         
Cleveland Clinic Cancer Center/Fairview Hospital Recruiting
Cleveland, Ohio, United States, 44111
Contact: Aaron T. Gerds    866-223-8100      
Principal Investigator: Aaron T. Gerds         
Cleveland Clinic Foundation Recruiting
Cleveland, Ohio, United States, 44195
Contact: Aaron T. Gerds    866-223-8100      
Principal Investigator: Aaron T. Gerds         
Ohio State University Comprehensive Cancer Center Recruiting
Columbus, Ohio, United States, 43210
Contact: Joanne M. Jeter    800-293-5066    Jamesline@osumc.edu   
Principal Investigator: Joanne M. Jeter         
Columbus Oncology and Hematology Associates Inc Recruiting
Columbus, Ohio, United States, 43214
Contact: Timothy D. Moore    614-488-2745    sheree@columbusccop.org   
Principal Investigator: Timothy D. Moore         
Riverside Methodist Hospital Recruiting
Columbus, Ohio, United States, 43214
Contact: Timothy D. Moore    614-488-2745    sheree@columbusccop.org   
Principal Investigator: Timothy D. Moore         
Good Samaritan Hospital - Dayton Recruiting
Dayton, Ohio, United States, 45406
Contact: Howard M. Gross    937-775-1350    som_dcop@wright.edu   
Principal Investigator: Howard M. Gross         
Miami Valley Hospital Recruiting
Dayton, Ohio, United States, 45409
Contact: Howard M. Gross    937-775-1350    som_dcop@wright.edu   
Principal Investigator: Howard M. Gross         
Dayton Physicians LLC-Samaritan North Recruiting
Dayton, Ohio, United States, 45415
Contact: Howard M. Gross    937-775-1350    som_dcop@wright.edu   
Principal Investigator: Howard M. Gross         
Samaritan North Health Center Recruiting
Dayton, Ohio, United States, 45415
Contact: Howard M. Gross    937-775-1350    som_dcop@wright.edu   
Principal Investigator: Howard M. Gross         
Oncology Hematology Care Inc-Healthplex Suspended
Fairfield, Ohio, United States, 45014
Armes Family Cancer Center Recruiting
Findlay, Ohio, United States, 45840
Contact: Howard M. Gross    937-775-1350    som_dcop@wright.edu   
Principal Investigator: Howard M. Gross         
Blanchard Valley Hospital Recruiting
Findlay, Ohio, United States, 45840
Contact: Howard M. Gross    937-775-1350    som_dcop@wright.edu   
Principal Investigator: Howard M. Gross         
Orion Cancer Care Suspended
Findlay, Ohio, United States, 45840
Dayton Physicians LLC-Atrium Recruiting
Franklin, Ohio, United States, 45005
Contact: Howard M. Gross    937-775-1350    som_dcop@wright.edu   
Principal Investigator: Howard M. Gross         
Dayton Physicians LLC-Wayne Recruiting
Greenville, Ohio, United States, 45331
Contact: Howard M. Gross    937-775-1350    som_dcop@wright.edu   
Principal Investigator: Howard M. Gross         
Wayne Hospital Recruiting
Greenville, Ohio, United States, 45331
Contact: Howard M. Gross    937-775-1350    som_dcop@wright.edu   
Principal Investigator: Howard M. Gross         
Greater Dayton Cancer Center Recruiting
Kettering, Ohio, United States, 45409
Contact: Howard M. Gross    937-775-1350    som_dcop@wright.edu   
Principal Investigator: Howard M. Gross         
Kettering Medical Center Recruiting
Kettering, Ohio, United States, 45429
Contact: Howard M. Gross    937-775-1350    som_dcop@wright.edu   
Principal Investigator: Howard M. Gross         
Toledo Clinic Cancer Centers-Maumee Recruiting
Maumee, Ohio, United States, 43537
Contact: Rex B. Mowat    800-444-3561      
Principal Investigator: Rex B. Mowat         
Toledo Radiation Oncology at Northwest Ohio Onocolgy Center Recruiting
Maumee, Ohio, United States, 43537
Contact: Rex B. Mowat    800-444-3561      
Principal Investigator: Rex B. Mowat         
Hillcrest Hospital Cancer Center Recruiting
Mayfield Heights, Ohio, United States, 44124
Contact: Aaron T. Gerds    866-223-8100      
Principal Investigator: Aaron T. Gerds         
Dayton Physicians LLC-Signal Point Recruiting
Middletown, Ohio, United States, 45042
Contact: Howard M. Gross    937-775-1350    som_dcop@wright.edu   
Principal Investigator: Howard M. Gross         
Licking Memorial Hospital Recruiting
Newark, Ohio, United States, 43055
Contact: Timothy D. Moore    614-488-2745    sheree@columbusccop.org   
Principal Investigator: Timothy D. Moore         
Newark Radiation Oncology Recruiting
Newark, Ohio, United States, 43055
Contact: Timothy D. Moore    614-488-2745    sheree@columbusccop.org   
Principal Investigator: Timothy D. Moore         
Saint Charles Hospital Suspended
Oregon, Ohio, United States, 43616
Mercy Health Perrysburg Cancer Center Recruiting
Perrysburg, Ohio, United States, 43551
Contact: Rex B. Mowat    800-444-3561      
Principal Investigator: Rex B. Mowat         
Southern Ohio Medical Center Recruiting
Portsmouth, Ohio, United States, 45662
Contact: Timothy D. Moore    614-488-2745    sheree@columbusccop.org   
Principal Investigator: Timothy D. Moore         
North Coast Cancer Care Recruiting
Sandusky, Ohio, United States, 44870
Contact: Aaron T. Gerds    866-223-8100      
Principal Investigator: Aaron T. Gerds         
Dayton Physicians LLC-Wilson Recruiting
Sidney, Ohio, United States, 45365
Contact: Howard M. Gross    937-775-1350    som_dcop@wright.edu   
Principal Investigator: Howard M. Gross         
University of Toledo Recruiting
Toledo, Ohio, United States, 43614
Contact: Roland T. Skeel    419-383-6583      
Principal Investigator: Roland T. Skeel         
Mercy Saint Anne Hospital Recruiting
Toledo, Ohio, United States, 43623
Contact: Rex B. Mowat    800-444-3561      
Principal Investigator: Rex B. Mowat         
Toledo Clinic Cancer Centers-Toledo Recruiting
Toledo, Ohio, United States, 43623
Contact: Rex B. Mowat    800-444-3561      
Principal Investigator: Rex B. Mowat         
Dayton Physicians LLC-Upper Valley Recruiting
Troy, Ohio, United States, 45373
Contact: Howard M. Gross    937-775-1350    som_dcop@wright.edu   
Principal Investigator: Howard M. Gross         
Upper Valley Medical Center Recruiting
Troy, Ohio, United States, 45373
Contact: Howard M. Gross    937-775-1350    som_dcop@wright.edu   
Principal Investigator: Howard M. Gross         
University Pointe Recruiting
West Chester, Ohio, United States, 45069
Contact: Nagla Abdel Karim    513-558-4553    uchealthnews@uc.edu   
Principal Investigator: Nagla Abdel Karim         
United States, Oklahoma
University of Oklahoma Health Sciences Center Recruiting
Oklahoma City, Oklahoma, United States, 73104
Contact: Alexandra P. Ikeguchi    405-271-8777    ou-clinical-trials@ouhsc.edu   
Principal Investigator: Alexandra P. Ikeguchi         
United States, Oregon
Saint Alphonsus Medical Center-Baker City Recruiting
Baker City, Oregon, United States, 97814
Contact: Christopher M. Reynolds    734-712-4673      
Principal Investigator: Christopher M. Reynolds         
Saint Charles Health System Recruiting
Bend, Oregon, United States, 97701
Contact: Alison K. Conlin    503-215-2614    CanRsrchStudies@providence.org   
Principal Investigator: Alison K. Conlin         
Clackamas Radiation Oncology Center Recruiting
Clackamas, Oregon, United States, 97015
Contact: Alison K. Conlin    503-215-2614    CanRsrchStudies@providence.org   
Principal Investigator: Alison K. Conlin         
Providence Oncology and Hematology Care Southeast Recruiting
Clackamas, Oregon, United States, 97015
Contact: Alison K. Conlin    503-215-2614    CanRsrchStudies@providence.org   
Principal Investigator: Alison K. Conlin         
Bay Area Hospital Recruiting
Coos Bay, Oregon, United States, 97420
Contact: Alison K. Conlin    503-215-2614    CanRsrchStudies@providence.org   
Principal Investigator: Alison K. Conlin         
Providence Newberg Medical Center Recruiting
Newberg, Oregon, United States, 97132
Contact: Alison K. Conlin    503-215-2614    CanRsrchStudies@providence.org   
Principal Investigator: Alison K. Conlin         
Saint Alphonsus Medical Center-Ontario Recruiting
Ontario, Oregon, United States, 97914
Contact: Christopher M. Reynolds    734-712-4673      
Principal Investigator: Christopher M. Reynolds         
Providence Willamette Falls Medical Center Recruiting
Oregon City, Oregon, United States, 97045
Contact: Alison K. Conlin    503-215-2614    CanRsrchStudies@providence.org   
Principal Investigator: Alison K. Conlin         
Providence Portland Medical Center Recruiting
Portland, Oregon, United States, 97213
Contact: Alison K. Conlin    503-215-2614    CanRsrchStudies@providence.org   
Principal Investigator: Alison K. Conlin         
Providence Saint Vincent Medical Center Recruiting
Portland, Oregon, United States, 97225
Contact: Alison K. Conlin    503-215-2614    CanRsrchStudies@providence.org   
Principal Investigator: Alison K. Conlin         
Oregon Health and Science University Recruiting
Portland, Oregon, United States, 97239
Contact: Matthew H. Taylor    503-494-1080    trials@ohsu.edu   
Principal Investigator: Matthew H. Taylor         
United States, Pennsylvania
Lehigh Valley Hospital-Cedar Crest Recruiting
Allentown, Pennsylvania, United States, 18103
Contact: Christopher M. Reynolds    734-712-4673      
Principal Investigator: Christopher M. Reynolds         
UPMC-Heritage Valley Health System Beaver Recruiting
Beaver, Pennsylvania, United States, 15009
Contact: Ahmad A. Tarhini    412-647-8073      
Principal Investigator: Ahmad A. Tarhini         
Saint Luke's University Hospital-Bethlehem Campus Recruiting
Bethlehem, Pennsylvania, United States, 18015
Contact: Sanjiv S. Agarwala    610-954-3582    infolink@slhn.org   
Principal Investigator: Sanjiv S. Agarwala         
Lehigh Valley Hospital - Muhlenberg Recruiting
Bethlehem, Pennsylvania, United States, 18017
Contact: Christopher M. Reynolds    734-712-4673      
Principal Investigator: Christopher M. Reynolds         
Christiana Care Health System-Concord Health Center Recruiting
Chadds Ford, Pennsylvania, United States, 19317
Contact: Gregory A. Masters    302-733-6227      
Principal Investigator: Gregory A. Masters         
Geisinger Medical Center Recruiting
Danville, Pennsylvania, United States, 17822
Contact: Joseph J. Vadakara    570-271-5251      
Principal Investigator: Joseph J. Vadakara         
UPMC Cancer Centers - Arnold Palmer Pavilion Recruiting
Greensburg, Pennsylvania, United States, 15601
Contact: Ahmad A. Tarhini    412-647-8073      
Principal Investigator: Ahmad A. Tarhini         
Penn State Milton S Hershey Medical Center Suspended
Hershey, Pennsylvania, United States, 17033-0850
UPMC-Johnstown/John P. Murtha Regional Cancer Center Recruiting
Johnstown, Pennsylvania, United States, 15901
Contact: Ahmad A. Tarhini    412-647-8073      
Principal Investigator: Ahmad A. Tarhini         
Geisinger Medical Oncology-Lewisburg Recruiting
Lewisburg, Pennsylvania, United States, 17837
Contact: Joseph J. Vadakara    570-271-5251      
Principal Investigator: Joseph J. Vadakara         
UPMC Cancer Center at UPMC McKeesport Recruiting
McKeesport, Pennsylvania, United States, 15132
Contact: Ahmad A. Tarhini    412-647-8073      
Principal Investigator: Ahmad A. Tarhini         
UPMC-Coraopolis/Heritage Valley Radiation Oncology Recruiting
Moon, Pennsylvania, United States, 15108
Contact: Ahmad A. Tarhini    412-647-8073      
Principal Investigator: Ahmad A. Tarhini         
UPMC-Magee Womens Hospital Recruiting
Pittsburgh, Pennsylvania, United States, 15213
Contact: Ahmad A. Tarhini    412-647-8073      
Principal Investigator: Ahmad A. Tarhini         
UPMC-Presbyterian Hospital Recruiting
Pittsburgh, Pennsylvania, United States, 15213
Contact: Ahmad A. Tarhini    412-647-8073      
Principal Investigator: Ahmad A. Tarhini         
UPMC-Saint Margaret Recruiting
Pittsburgh, Pennsylvania, United States, 15215
Contact: Ahmad A. Tarhini    412-647-8073      
Principal Investigator: Ahmad A. Tarhini         
University of Pittsburgh Cancer Institute (UPCI) Recruiting
Pittsburgh, Pennsylvania, United States, 15232
Contact: Ahmad A. Tarhini    412-647-8073      
Principal Investigator: Ahmad A. Tarhini         
UPMC-Shadyside Hospital Recruiting
Pittsburgh, Pennsylvania, United States, 15232
Contact: Ahmad A. Tarhini    412-647-8073      
Principal Investigator: Ahmad A. Tarhini         
UPMC-Passavant Hospital Recruiting
Pittsburgh, Pennsylvania, United States, 15237
Contact: Ahmad A. Tarhini    412-647-8073      
Principal Investigator: Ahmad A. Tarhini         
UPMC-Saint Clair Hospital Cancer Center Recruiting
Pittsburgh, Pennsylvania, United States, 15243
Contact: Ahmad A. Tarhini    412-647-8073      
Principal Investigator: Ahmad A. Tarhini         
Guthrie Medical Group PC-Robert Packer Hospital Recruiting
Sayre, Pennsylvania, United States, 18840
Contact: Philip A. Lowry    508-856-3216    cancer.research@umassmed.edu   
Principal Investigator: Philip A. Lowry         
UPMC Cancer Center at UPMC Northwest Recruiting
Seneca, Pennsylvania, United States, 16346
Contact: Ahmad A. Tarhini    412-647-8073      
Principal Investigator: Ahmad A. Tarhini         
UPMC Uniontown Hospital Radiation Oncology Recruiting
Uniontown, Pennsylvania, United States, 15401
Contact: Ahmad A. Tarhini    412-647-8073      
Principal Investigator: Ahmad A. Tarhini         
UPMC Washington Hospital Radiation Oncology Recruiting
Washington, Pennsylvania, United States, 15301
Contact: Ahmad A. Tarhini    412-647-8073      
Principal Investigator: Ahmad A. Tarhini         
Reading Hospital Recruiting
West Reading, Pennsylvania, United States, 19611
Contact: Terrence P. Cescon    610-988-9323      
Principal Investigator: Terrence P. Cescon         
United States, Rhode Island
Rhode Island Hospital Recruiting
Providence, Rhode Island, United States, 02903
Contact: Maria Constantinou    401-444-1488      
Principal Investigator: Maria Constantinou         
United States, South Carolina
Roper Hospital Suspended
Charleston, South Carolina, United States, 29401
Charleston Hematology Oncology Associates-Roper Suspended
Charleston, South Carolina, United States, 29403
Charleston Hematology Oncology Associates PA-St. Francis Suspended
Charleston, South Carolina, United States, 29414
Medical University of South Carolina Recruiting
Charleston, South Carolina, United States, 29425
Contact: Daniel Y. Reuben    843-792-9321      
Principal Investigator: Daniel Y. Reuben         
Greenville Health System Cancer Institute-Easley Recruiting
Easley, South Carolina, United States, 29640
Contact: Jeffrey K. Giguere    864-241-6251      
Principal Investigator: Jeffrey K. Giguere         
Saint Francis Hospital Recruiting
Greenville, South Carolina, United States, 29601
Contact: Robert D. Siegel    864-255-1713      
Principal Investigator: Robert D. Siegel         
Greenville Health System Cancer Institute-Butternut Recruiting
Greenville, South Carolina, United States, 29605
Contact: Jeffrey K. Giguere    864-241-6251      
Principal Investigator: Jeffrey K. Giguere         
Greenville Health System Cancer Institute-Faris Recruiting
Greenville, South Carolina, United States, 29605
Contact: Jeffrey K. Giguere    864-241-6251      
Principal Investigator: Jeffrey K. Giguere         
Greenville Memorial Hospital Recruiting
Greenville, South Carolina, United States, 29605
Contact: Jeffrey K. Giguere    864-241-6251      
Principal Investigator: Jeffrey K. Giguere         
Saint Francis Cancer Center Recruiting
Greenville, South Carolina, United States, 29607
Contact: Robert D. Siegel    864-255-1713      
Principal Investigator: Robert D. Siegel         
Greenville Health System Cancer Institute-Eastside Recruiting
Greenville, South Carolina, United States, 29615
Contact: Jeffrey K. Giguere    864-241-6251      
Principal Investigator: Jeffrey K. Giguere         
Greenville Health System Cancer Institute-Greer Recruiting
Greer, South Carolina, United States, 29650
Contact: Jeffrey K. Giguere    864-241-6251      
Principal Investigator: Jeffrey K. Giguere         
The Radiation Oncology Center-Hilton Head/Bluffton Recruiting
Hilton Head Island, South Carolina, United States, 29926
Contact: Howard A. Zaren    912-819-5704      
Principal Investigator: Howard A. Zaren         
Greenville Health System Cancer Institute-Seneca Recruiting
Seneca, South Carolina, United States, 29672
Contact: Jeffrey K. Giguere    864-241-6251      
Principal Investigator: Jeffrey K. Giguere         
Greenville Health System Cancer Institute-Spartanburg Recruiting
Spartanburg, South Carolina, United States, 29307
Contact: Jeffrey K. Giguere    864-241-6251      
Principal Investigator: Jeffrey K. Giguere         
United States, South Dakota
Sanford Cancer Center-Oncology Clinic Recruiting
Sioux Falls, South Dakota, United States, 57104
Contact: Preston D. Steen    701-234-6161      
Principal Investigator: Preston D. Steen         
Avera Cancer Institute Recruiting
Sioux Falls, South Dakota, United States, 57105
Contact: Amy K. Krie    888-634-7268    oncregulatory@avera.org   
Principal Investigator: Amy K. Krie         
Sanford USD Medical Center - Sioux Falls Recruiting
Sioux Falls, South Dakota, United States, 57117-5134
Contact: Preston D. Steen    701-234-6161      
Principal Investigator: Preston D. Steen         
United States, Tennessee
Wellmont Bristol Regional Medical Center Suspended
Bristol, Tennessee, United States, 37620
Wellmont Medical Associates Oncology and Hematology-Bristol Suspended
Bristol, Tennessee, United States, 37620
Memorial Hospital Suspended
Chattanooga, Tennessee, United States, 37404
Vanderbilt-Ingram Cancer Center Cool Springs Recruiting
Franklin, Tennessee, United States, 37067
Contact: Kristin K. Ancell    800-811-8480      
Principal Investigator: Kristin K. Ancell         
Pulmonary Medicine Center of Chattanooga-Hixson Recruiting
Hixson, Tennessee, United States, 37343
Contact: Mehmet S. Copur    800-998-2119      
Principal Investigator: Mehmet S. Copur         
Wellmont Holston Valley Hospital and Medical Center Recruiting
Kingsport, Tennessee, United States, 37660
Contact: Asheesh Shipstone    423-578-8538      
Principal Investigator: Asheesh Shipstone         
Wellmont Medical Associates Oncology and Hematology-Kingsport Recruiting
Kingsport, Tennessee, United States, 37660
Contact: Asheesh Shipstone    423-578-8538      
Principal Investigator: Asheesh Shipstone         
Thompson Cancer Survival Center Recruiting
Knoxville, Tennessee, United States, 37916
Contact: Wenqing Zhang    865-331-1812      
Principal Investigator: Wenqing Zhang         
Thompson Cancer Survival Center - West Recruiting
Knoxville, Tennessee, United States, 37932
Contact: Wenqing Zhang    865-331-1812      
Principal Investigator: Wenqing Zhang         
Vanderbilt Breast Center at One Hundred Oaks Recruiting
Nashville, Tennessee, United States, 37204
Contact: Kristin K. Ancell    800-811-8480      
Principal Investigator: Kristin K. Ancell         
Vanderbilt University/Ingram Cancer Center Recruiting
Nashville, Tennessee, United States, 37232
Contact: Kristin K. Ancell    800-811-8480      
Principal Investigator: Kristin K. Ancell         
Thompson Oncology Group-Oak Ridge Recruiting
Oak Ridge, Tennessee, United States, 37830
Contact: Wenqing Zhang    865-331-1812      
Principal Investigator: Wenqing Zhang         
Memorial GYN Plus Recruiting
Ooltewah, Tennessee, United States, 37363
Contact: Mehmet S. Copur    800-998-2119      
Principal Investigator: Mehmet S. Copur         
United States, Texas
Saint Joseph Regional Cancer Center Recruiting
Bryan, Texas, United States, 77802
Contact: Mehmet S. Copur    800-998-2119      
Principal Investigator: Mehmet S. Copur         
Parkland Memorial Hospital Suspended
Dallas, Texas, United States, 75235
UT Southwestern/Simmons Cancer Center-Dallas Suspended
Dallas, Texas, United States, 75390
United States, Virginia
Lynchburg Hematology-Oncology Clinic Suspended
Lynchburg, Virginia, United States, 24501
Southwest VA Regional Cancer Center Recruiting
Norton, Virginia, United States, 24273
Contact: Asheesh Shipstone    423-578-8538      
Principal Investigator: Asheesh Shipstone         
Virginia Commonwealth University/Massey Cancer Center Recruiting
Richmond, Virginia, United States, 23298
Contact: Andrew Poklepovic    804-628-1939      
Principal Investigator: Andrew Poklepovic         
United States, Washington
Providence Regional Cancer System-Aberdeen Recruiting
Aberdeen, Washington, United States, 98520
Contact: Alison K. Conlin    503-215-2614    CanRsrchStudies@providence.org   
Principal Investigator: Alison K. Conlin         
Cancer Care Center at Island Hospital Recruiting
Anacortes, Washington, United States, 98221
Contact: Alison K. Conlin    503-215-2614    CanRsrchStudies@providence.org   
Principal Investigator: Alison K. Conlin         
MultiCare Auburn Medical Center Recruiting
Auburn, Washington, United States, 98001
Contact: John A. Keech    253-403-2394      
Principal Investigator: John A. Keech         
Virginia Mason Bainbridge Island Medical Center Recruiting
Bainbridge Island, Washington, United States, 98110
Contact: John A. Keech    253-403-2394      
Principal Investigator: John A. Keech         
Overlake Hospital Medical Center Recruiting
Bellevue, Washington, United States, 98004
Contact: John A. Keech    253-403-2394      
Principal Investigator: John A. Keech         
Swedish Cancer Institute-Eastside Oncology Hematology Suspended
Bellevue, Washington, United States, 98005
PeaceHealth Saint Joseph Medical Center Recruiting
Bellingham, Washington, United States, 98225
Contact: Alison K. Conlin    503-215-2614    CanRsrchStudies@providence.org   
Principal Investigator: Alison K. Conlin         
Harrison HealthPartners Hematology and Oncology-Bremerton Recruiting
Bremerton, Washington, United States, 98310
Contact: Mehmet S. Copur    800-998-2119      
Principal Investigator: Mehmet S. Copur         
Harrison Medical Center Recruiting
Bremerton, Washington, United States, 98310
Contact: Mehmet S. Copur    800-998-2119      
Principal Investigator: Mehmet S. Copur         
Highline Medical Center-Main Campus Recruiting
Burien, Washington, United States, 98166
Contact: Mehmet S. Copur    800-998-2119      
Principal Investigator: Mehmet S. Copur         
Providence Regional Cancer System-Centralia Recruiting
Centralia, Washington, United States, 98531
Contact: Alison K. Conlin    503-215-2614    CanRsrchStudies@providence.org   
Principal Investigator: Alison K. Conlin         
Swedish Medical Center-Edmonds Recruiting
Edmonds, Washington, United States, 98026
Contact: Alison K. Conlin    503-215-2614    CanRsrchStudies@providence.org   
Principal Investigator: Alison K. Conlin         
Saint Elizabeth Hospital Recruiting
Enumclaw, Washington, United States, 98022
Contact: Mehmet S. Copur    800-998-2119      
Principal Investigator: Mehmet S. Copur         
Providence Regional Cancer Partnership Recruiting
Everett, Washington, United States, 98201
Contact: Alison K. Conlin    503-215-2614    CanRsrchStudies@providence.org   
Principal Investigator: Alison K. Conlin         
Virginia Mason Federal Way Medical Center Recruiting
Federal Way, Washington, United States, 98002
Contact: John A. Keech    253-403-2394      
Principal Investigator: John A. Keech         
Saint Francis Hospital Recruiting
Federal Way, Washington, United States, 98003
Contact: Mehmet S. Copur    800-998-2119      
Principal Investigator: Mehmet S. Copur         
Tacoma/Valley Radiation Oncology Centers-Gig Harbor Recruiting
Gig Harbor, Washington, United States, 98332
Contact: John A. Keech    253-403-2394      
Principal Investigator: John A. Keech         
MultiCare Gig Harbor Medical Park Recruiting
Gig Harbor, Washington, United States, 98335
Contact: John A. Keech    253-403-2394      
Principal Investigator: John A. Keech         
Swedish Cancer Institute-Issaquah Recruiting
Issaquah, Washington, United States, 98029
Contact: Alison K. Conlin    503-215-2614    CanRsrchStudies@providence.org   
Principal Investigator: Alison K. Conlin         
Northwest Cancer Clinic Recruiting
Kennewick, Washington, United States, 99336
Contact: John A. Keech    253-403-2394      
Principal Investigator: John A. Keech         
Providence Regional Cancer System-Lacey Recruiting
Lacey, Washington, United States, 98503
Contact: Alison K. Conlin    503-215-2614    CanRsrchStudies@providence.org   
Principal Investigator: Alison K. Conlin         
Saint Clare Hospital Recruiting
Lakewood, Washington, United States, 98499
Contact: Mehmet S. Copur    800-998-2119      
Principal Investigator: Mehmet S. Copur         
PeaceHealth Saint John Medical Center Recruiting
Longview, Washington, United States, 98632
Contact: Alison K. Conlin    503-215-2614    CanRsrchStudies@providence.org   
Principal Investigator: Alison K. Conlin         
Virginia Mason Lynnwood Medical Center Recruiting
Lynnwood, Washington, United States, 98036
Contact: John A. Keech    253-403-2394      
Principal Investigator: John A. Keech         
Jefferson Healthcare Recruiting
Port Townsend, Washington, United States, 98368
Contact: John A. Keech    253-403-2394      
Principal Investigator: John A. Keech         
Harrison HealthPartners Hematology and Oncology-Poulsbo Recruiting
Poulsbo, Washington, United States, 98370
Contact: Mehmet S. Copur    800-998-2119      
Principal Investigator: Mehmet S. Copur         
Peninsula Cancer Center Recruiting
Poulsbo, Washington, United States, 98370
Contact: John A. Keech    253-403-2394      
Principal Investigator: John A. Keech         
MultiCare Good Samaritan Hospital Recruiting
Puyallup, Washington, United States, 98372
Contact: John A. Keech    253-403-2394      
Principal Investigator: John A. Keech         
Tacoma/Valley Radiation Oncology Centers-Puyallup Recruiting
Puyallup, Washington, United States, 98372
Contact: John A. Keech    253-403-2394      
Principal Investigator: John A. Keech         
Valley Medical Center Recruiting
Renton, Washington, United States, 98055
Contact: John A. Keech    253-403-2394      
Principal Investigator: John A. Keech         
Virginia Mason Medical Center Recruiting
Seattle, Washington, United States, 98101
Contact: John A. Keech    253-403-2394      
Principal Investigator: John A. Keech         
Minor and James Medical PLLC Suspended
Seattle, Washington, United States, 98104
Pacific Gynecology Specialists Recruiting
Seattle, Washington, United States, 98104
Contact: Alison K. Conlin    503-215-2614    CanRsrchStudies@providence.org   
Principal Investigator: Alison K. Conlin         
Swedish Medical Center-Ballard Campus Recruiting
Seattle, Washington, United States, 98107
Contact: Alison K. Conlin    503-215-2614    CanRsrchStudies@providence.org   
Principal Investigator: Alison K. Conlin         
Group Health Cooperative-Seattle Recruiting
Seattle, Washington, United States, 98112
Contact: Alison K. Conlin    503-215-2614    CanRsrchStudies@providence.org   
Principal Investigator: Alison K. Conlin         
Swedish Medical Center-First Hill Recruiting
Seattle, Washington, United States, 98122-4307
Contact: Alison K. Conlin    503-215-2614    CanRsrchStudies@providence.org   
Principal Investigator: Alison K. Conlin         
Swedish Medical Center-Cherry Hill Recruiting
Seattle, Washington, United States, 98122-5711
Contact: Alison K. Conlin    503-215-2614    CanRsrchStudies@providence.org   
Principal Investigator: Alison K. Conlin         
Providence Regional Cancer System-Shelton Recruiting
Shelton, Washington, United States, 98584
Contact: Alison K. Conlin    503-215-2614    CanRsrchStudies@providence.org   
Principal Investigator: Alison K. Conlin         
Rockwood Clinic Cancer Treatment Center-Valley Recruiting
Spokane Valley, Washington, United States, 99216
Contact: Alison K. Conlin    503-215-2614    CanRsrchStudies@providence.org   
Principal Investigator: Alison K. Conlin         
Rockwood Cancer Treatment Center-DHEC-Downtown Recruiting
Spokane, Washington, United States, 99204
Contact: Alison K. Conlin    503-215-2614    CanRsrchStudies@providence.org   
Principal Investigator: Alison K. Conlin         
Rockwood North Cancer Treatment Center Recruiting
Spokane, Washington, United States, 99218
Contact: Alison K. Conlin    503-215-2614    CanRsrchStudies@providence.org   
Principal Investigator: Alison K. Conlin         
Tacoma/Valley Radiation Oncology Centers-Jackson Hall Recruiting
Tacoma, Washington, United States, 97405
Contact: John A. Keech    253-403-2394      
Principal Investigator: John A. Keech         
Franciscan Research Center-Northwest Medical Plaza Recruiting
Tacoma, Washington, United States, 98405
Contact: Mehmet S. Copur    800-998-2119      
Principal Investigator: Mehmet S. Copur         
MultiCare Tacoma General Hospital Recruiting
Tacoma, Washington, United States, 98405
Contact: John A. Keech    253-403-2394      
Principal Investigator: John A. Keech         
Northwest Medical Specialties PLLC Recruiting
Tacoma, Washington, United States, 98405
Contact: Mehmet S. Copur    800-998-2119      
Principal Investigator: Mehmet S. Copur         
Northwest NCI Community Oncology Research Program Recruiting
Tacoma, Washington, United States, 98405
Contact: John A. Keech    253-403-2394      
Principal Investigator: John A. Keech         
Tacoma/Valley Radiation Oncology Centers-Saint Joe's Recruiting
Tacoma, Washington, United States, 98405
Contact: John A. Keech    253-403-2394      
Principal Investigator: John A. Keech         
PeaceHealth Southwest Medical Center Recruiting
Vancouver, Washington, United States, 98664
Contact: Alison K. Conlin    503-215-2614    CanRsrchStudies@providence.org   
Principal Investigator: Alison K. Conlin         
Providence Saint Mary Regional Cancer Center Recruiting
Walla Walla, Washington, United States, 99362
Contact: Alison K. Conlin    503-215-2614    CanRsrchStudies@providence.org   
Principal Investigator: Alison K. Conlin         
Providence Regional Cancer System-Yelm Recruiting
Yelm, Washington, United States, 98597
Contact: Alison K. Conlin    503-215-2614    CanRsrchStudies@providence.org   
Principal Investigator: Alison K. Conlin         
United States, West Virginia
West Virginia University Charleston Recruiting
Charleston, West Virginia, United States, 25304
Contact: Steven J. Jubelirer    304-344-3457      
Principal Investigator: Steven J. Jubelirer         
Edwards Comprehensive Cancer Center Recruiting
Huntington, West Virginia, United States, 25701
Contact: Maria R. Tria Tirona    304-399-6617      
Principal Investigator: Maria R. Tria Tirona         
West Virginia University Healthcare Recruiting
Morgantown, West Virginia, United States, 26506
Contact: Inderjit Mehmi    304-293-7374    cancertrialsinfo@hsc.wvu.edu   
Principal Investigator: Inderjit Mehmi         
United States, Wisconsin
Langlade Hospital and Cancer Center Recruiting
Antigo, Wisconsin, United States, 54409
Contact: Harish G. Ahuja    877-405-6866      
Principal Investigator: Harish G. Ahuja         
Marshfield Clinic-Chippewa Center Recruiting
Chippewa Falls, Wisconsin, United States, 54729
Contact: Seth O. Fagbemi    715-389-4457      
Principal Investigator: Seth O. Fagbemi         
Marshfield Clinic Cancer Center at Sacred Heart Recruiting
Eau Claire, Wisconsin, United States, 54701
Contact: Seth O. Fagbemi    715-389-4457      
Principal Investigator: Seth O. Fagbemi         
Green Bay Oncology at Saint Vincent Hospital Recruiting
Green Bay, Wisconsin, United States, 54301-3526
Contact: Brian L. Burnette    920-433-8889      
Principal Investigator: Brian L. Burnette         
Saint Vincent Hospital Cancer Center Green Bay Recruiting
Green Bay, Wisconsin, United States, 54301
Contact: Brian L. Burnette    920-433-8889      
Principal Investigator: Brian L. Burnette         
Green Bay Oncology Limited at Saint Mary's Hospital Recruiting
Green Bay, Wisconsin, United States, 54303
Contact: Brian L. Burnette    920-433-8889      
Principal Investigator: Brian L. Burnette         
Saint Vincent Hospital Cancer Center at Saint Mary's Recruiting
Green Bay, Wisconsin, United States, 54303
Contact: Brian L. Burnette    920-433-8889      
Principal Investigator: Brian L. Burnette         
University of Wisconsin Hospital and Clinics Recruiting
Madison, Wisconsin, United States, 53792
Contact: Mark R. Albertini    877-405-6866      
Principal Investigator: Mark R. Albertini         
Holy Family Memorial Hospital Recruiting
Manitowoc, Wisconsin, United States, 54221
Contact: Brian L. Burnette    920-433-8889      
Principal Investigator: Brian L. Burnette         
Marshfield Clinic Recruiting
Marshfield, Wisconsin, United States, 54449
Contact: Seth O. Fagbemi    715-389-4457      
Principal Investigator: Seth O. Fagbemi         
Wheaton Franciscan Healthcare - Saint Joseph Suspended
Milwaukee, Wisconsin, United States, 53210
Froedtert and the Medical College of Wisconsin Recruiting
Milwaukee, Wisconsin, United States, 53226
Contact: Amy K. Harker-Murray    414-805-4380      
Principal Investigator: Amy K. Harker-Murray         
Marshfield Clinic-Minocqua Center Recruiting
Minocqua, Wisconsin, United States, 54548
Contact: Seth O. Fagbemi    715-389-4457      
Principal Investigator: Seth O. Fagbemi         
Green Bay Oncology - Oconto Falls Recruiting
Oconto Falls, Wisconsin, United States, 54154
Contact: Brian L. Burnette    920-433-8889      
Principal Investigator: Brian L. Burnette         
Lakeview Medical Center-Marshfield Clinic Recruiting
Rice Lake, Wisconsin, United States, 54868
Contact: Seth O. Fagbemi    715-389-4457      
Principal Investigator: Seth O. Fagbemi         
Marshfield Clinic-Rice Lake Center Recruiting
Rice Lake, Wisconsin, United States, 54868
Contact: Seth O. Fagbemi    715-389-4457      
Principal Investigator: Seth O. Fagbemi         
HSHS Saint Nicholas Hospital Recruiting
Sheboygan, Wisconsin, United States, 53081
Contact: Brian L. Burnette    920-433-8889      
Principal Investigator: Brian L. Burnette         
Saint Vincent Hospital Cancer Center at Sturgeon Bay Recruiting
Sturgeon Bay, Wisconsin, United States, 54235-1495
Contact: Brian L. Burnette    920-433-8889      
Principal Investigator: Brian L. Burnette         
Green Bay Oncology - Sturgeon Bay Recruiting
Sturgeon Bay, Wisconsin, United States, 54235
Contact: Brian L. Burnette    920-433-8889      
Principal Investigator: Brian L. Burnette         
Aspirus Regional Cancer Center Recruiting
Wausau, Wisconsin, United States, 54401
Contact: Harish G. Ahuja    877-405-6866      
Principal Investigator: Harish G. Ahuja         
Aspirus UW Cancer Center Recruiting
Wisconsin Rapids, Wisconsin, United States, 54494
Contact: Harish G. Ahuja    877-405-6866      
Principal Investigator: Harish G. Ahuja         
Sponsors and Collaborators
National Cancer Institute (NCI)
Investigators
Principal Investigator: Michael Atkins ECOG-ACRIN Cancer Research Group
  More Information

Responsible Party: National Cancer Institute (NCI)
ClinicalTrials.gov Identifier: NCT02224781     History of Changes
Other Study ID Numbers: NCI-2014-01747
NCI-2014-01747 ( Registry Identifier: CTRP (Clinical Trial Reporting Program) )
EA6134
EA6134 ( Other Identifier: ECOG-ACRIN Cancer Research Group )
EA6134 ( Other Identifier: CTEP )
U10CA180820 ( U.S. NIH Grant/Contract )
Study First Received: August 22, 2014
Last Updated: July 20, 2017

Additional relevant MeSH terms:
Melanoma
Neuroendocrine Tumors
Neuroectodermal Tumors
Neoplasms, Germ Cell and Embryonal
Neoplasms by Histologic Type
Neoplasms
Neoplasms, Nerve Tissue
Nevi and Melanomas
Nivolumab
Trametinib
Dabrafenib
Antibodies, Monoclonal
Antineoplastic Agents
Immunologic Factors
Physiological Effects of Drugs
Protein Kinase Inhibitors
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action

ClinicalTrials.gov processed this record on July 21, 2017